All conditions

Obesity

Plain English clinical trial information, updated daily from ClinicalTrials.gov and public government registries. Not medical advice.

5328
Trials on record
543
Recruiting now
13
Australian sites
26
Phase 3 trials
2
PBS medicines
How these figures are counted
  • Trials on record is every trial tagged to this condition at any stage, except those withdrawn before starting or terminated early. Most are completed rather than ongoing, so this is a measure of research history, not of current activity. It is also smaller than the sitewide "trials tracked" figure, which does include withdrawn and terminated trials.
  • Recruiting now counts only trials whose registry status is "Recruiting". Trials listed as not yet recruiting or enrolling by invitation are excluded, so this understates how many may open to new participants soon.
  • Australian sites counts trials counted under "Recruiting now" that list at least one Australian site. A site being listed does not mean it is currently enrolling, and Australian trials registered only on ANZCTR are not counted yet, so this understates local availability.
  • Phase 3 trials counts trials counted under "Recruiting now" that are at Phase 3.

Find recruiting trials for Obesity →

Get alerts when Obesity trials change ↗

Voxsanity currently covers 103 conditions. We are expanding coverage regularly.

Understanding Obesity

Obesity is a medical condition where a person has an amount of body fat that can put strain on their health. Doctors often use a measurement called BMI (Body Mass Index), which compares a person's weight to their height, as one way to identify the condition — though other factors are also considered. Obesity is recognised as a complex, long-term health condition that can be linked to a range of other issues, including heart disease, type 2 diabetes, and joint problems. It is not simply a matter of willpower or lifestyle choices; genetics, hormones, mental health, medications, and social circumstances can all play a role.

Obesity is very common in Australia. Research suggests that around two in three Australian adults are living with either overweight or obesity, making it one of the most widespread health concerns in the country. It can affect people of all ages, backgrounds, and income levels, and rates have been rising steadily over recent decades. Children and young people can also be affected.

When it comes to managing obesity, there is no single approach that works for everyone. Treatment is usually tailored to the individual and may involve a team of health professionals, such as a GP, dietitian, exercise physiologist, or psychologist. General approaches can include changes to eating patterns, increased physical activity, support for mental health, medications, and in some cases, surgery. The goal is typically to improve overall health and reduce the risk of related conditions, rather than focusing purely on a number on the scales. Your doctor or health team is the best starting point for understanding what options may be suitable for you.

This overview is an AI generated summary written from public medical sources and checked on a sample basis. It is general information, not medical advice or a diagnosis. Always speak with your doctor about your situation. How we use AI

Can you access treatment for Obesity in Australia right now? Here's what's publicly known.

Information on this site does not constitute medical advice. Data is sourced from publicly available government registries. Always consult your doctor before making any health decisions. Trial status should be verified directly with the trial site.

Updated regularly from public government registries

PBS-subsidised medicines for Obesity

2 medicines listed on the PBS for Obesity. Filter by authority type, or open the full table below.

What the authority types mean Unrestricted: no clinical criteria; a doctor can prescribe it on the PBS for any appropriate use. Restricted benefit: subsidised only for the specific conditions or uses set out by the PBS. Streamlined authority: restricted, but the doctor does not need prior approval; they record a streamlined authority code confirming you meet the criteria. Authority required: restricted, and the doctor must get prior approval from Services Australia (by phone or online) before it is subsidised. Source: Pharmaceutical Benefits Scheme (pbs.gov.au).
Full PBS medicines table 2 listed

These medicines are listed on the Pharmaceutical Benefits Scheme (PBS) for the specific indications shown. A listing does not mean a medicine is right for you; your doctor decides what is appropriate. Prices shown are the PBS-determined dispensed price. Most patients pay only the standard co-payment, up to AU$25.00 per script (general) or AU$7.70 (concession or Safety Net) in 2026, with the Australian Government subsidising the rest.

Medicine Brand(s) Listed for
Somatropin Genotropin GoQuick, Genotropin MiniQuick, Saizen +6 more Hypothalamic-pituitary disease secondary to a structural lesion, with hypothalamic obesity driven growth AU$87.56 Authority required
Orlistat Xenical Obesity AU$113.08 Authority required

Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.

Research pipeline

Where trials for Obesity currently sit in the development pipeline. The funnel shape shows how few drugs reach later phases in general; the counts are this condition's actual trial numbers.

Phase success rates are industry-wide historical averages, not predictions for specific trials. Learn how trials work →

Most active research sponsors

Organisations with the most recruiting trials for Obesity.

View sponsor profile
View sponsor profile
View sponsor profile
View sponsor profile
View sponsor profile

Where trials are running

Clinical trial sites for Obesity by country. Australia is highlighted.

Showing the top 10 of 63 countries with trial sites.

Clinical trials for Obesity

Showing 546 of 546 trials

The plain English eligibility text on each trial below is an AI generated summary of the official criteria, checked on a sample basis. How we use AI

🇦🇺 NCT00960843 · Ethicon Endo-Surgery Not Applicable · 2 countries Completed
Completed Not Applicable Est. completion 1 November 2010
🇦🇺 AU🇨🇿 CZ

**Who might be able to join this trial:** - You are able to understand, follow instructions, and give your agreement to participate. - You are at least 18 years old when joining the trial. - Your BMI was between 35 and 55 before you had your gastric band device implanted. - You received a specific type of gastric band...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
🇦🇺 NCT03649477 · Levo Therapeutics, Inc. Phase 3 · 3 countries Completed
Completed Phase 3 Est. completion 13 May 2020
🇦🇺 AU🇨🇦 CA🇺🇸 US

**Who might be able to join this trial:** - You have been diagnosed with Prader-Willi syndrome (PWS) confirmed by genetic testing - A parent or legal guardian is willing and able to sign a consent form on the participant's behalf, and the participant themselves can sign an assent form if appropriate - You are in PWS Nu...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 NCT07173335 · University of Sydney Not Applicable · 1 country Not Yet Recruiting
Not Yet Recruiting Not Applicable Est. completion 29 February 2028
🇦🇺 AU

**Who might be able to join this trial:** - You are 18 years old or older and have had pain or physical difficulty in your knee, hip, or lower back for more than three months. - Your pain over the past week has been at least a 3 out of 10 on average, or your pain has interfered at least "somewhat" with your daily life...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
🇦🇺 NCT03441451 · Monash University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇦🇺 AU

"Who might be able to join this trial: - People with a Body Mass Index (BMI) greater than 30 kg/m² (this is a measure of body weight relative to height, and a BMI over 30 is generally classified as obese) Who may not be able to join: - Women who are currently pregnant Important: Always verify eligibility with the tri...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
🇦🇺 NCT06545435 · University of Roma La Sapienza Not Applicable · 6 countries Recruiting
Recruiting Not Applicable Est. completion 30 June 2025
🇦🇺 AU🇧🇷 BR🇨🇦 CA🇮🇹 IT🇵🇹 PT🇺🇸 US

**Who might be able to join this trial:** - Adults who have obesity, meaning a body mass index (BMI) of 30 or higher - People aged 18 years or older - People who have already had two specific body composition measurements taken — one using a DXA scan (a type of low-dose X-ray that measures body fat and muscle) and one...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
🇦🇺 NCT06859853 · Shanghai Minwei Biotechnology Co., Ltd Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 25 September 2025
🇦🇺 AU

**Who might be able to join this trial:** - Adults aged 18 to 50 years of any race or gender. - For the single-dose part of the trial (Part A): people with a body mass index (a measure of weight relative to height) between 19.0 and 40.0. - For the multiple-dose part of the trial (Part B): people with a body mass index...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 NCT06894498 · Boston Scientific Corporation Not Applicable · 7 countries Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇦🇺 AU🇫🇷 FR🇮🇳 IN🇮🇹 IT🇸🇦 SA🇬🇧 GB🇺🇸 US

Who might be able to join this trial: - People who were 18 years of age or older at the time of their stomach-stitching (ESG) procedure - People who had a body mass index (BMI) between 30 and 50 at the time of their ESG procedure, which was performed using a specific device called the Overstitch Endoscopic Suturing Sys...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
🇦🇺 NCT06938269 · Shanghai Minwei Biotechnology Co., Ltd Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 1 March 2026
🇦🇺 AU

**Who might be able to join this trial:** - Adults between 18 and 60 years old (at least 80% of participants must be Caucasian, as of 2 September 2025) - For the single-dose part of the trial (Part A): people with a body mass index (BMI) between 19.0 and 40.0, and a body weight between 65 kg and 130 kg - For the multi...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 NCT07037433 · Amgen Phase 3 · 36 countries Recruiting
Recruiting Phase 3 Est. completion 30 June 2028
🇦🇷 AR🇦🇺 AU🇦🇹 AT🇧🇪 BE🇧🇷 BR🇧🇬 BG🇨🇦 CA🇨🇱 CL +28 more

**Who might be able to join this trial:** - People who are 45 years of age or older at the time of screening. - People with a body mass index (BMI) of 27.0 or higher at the time of screening (this is a standard measure of body weight relative to height). - People with a documented history of cardiovascular disease cau...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 NCT07226765 · Amgen Phase 3 · 11 countries Recruiting
Recruiting Phase 3 Est. completion 29 September 2027
🇦🇺 AU🇧🇷 BR🇨🇦 CA🇨🇿 CZ🇫🇷 FR🇩🇪 DE🇭🇺 HU🇯🇵 JP +3 more

**Who might be able to join this trial:** - Your sleep study (overnight breathing test) must show that you stop breathing or have disrupted breathing at least 15 times per hour. - Your Body Mass Index (BMI) — a measure of weight relative to height — must be 27 or higher at the time of your initial check-up. - You must...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 NCT07253285 · Novo Nordisk A/S Phase 3 · 26 countries Recruiting
Recruiting Phase 3 Est. completion 20 March 2030
🇦🇺 AU🇦🇹 AT🇧🇪 BE🇧🇬 BG🇨🇳 CN🇨🇴 CO🇭🇷 HR🇩🇰 DK +18 more

**Who might be able to join this trial:** - A parent, guardian, or legal representative must agree to the child taking part by signing a consent form before any study activities begin, and the child must also give their agreement (by signing or speaking their agreement, depending on their age and local rules). - Child...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 NCT07284875 · Kailera Phase 3 · 5 countries Recruiting
Recruiting Phase 3 Est. completion 28 February 2028
🇦🇷 AR🇦🇺 AU🇳🇿 NZ🇬🇧 GB🇺🇸 US

**Who might be able to join this trial:** - People with a Body Mass Index (BMI) of 30 or higher, OR a BMI of 27 or higher combined with a prior diagnosis of at least one of the following: high blood pressure, abnormal cholesterol or fat levels in the blood, obstructive sleep apnea (where breathing repeatedly stops dur...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 NCT07284901 · Kailera Phase 3 · 4 countries Recruiting
Recruiting Phase 3 Est. completion 27 March 2028
🇦🇷 AR🇦🇺 AU🇳🇿 NZ🇺🇸 US

Who might be able to join this trial: - People who have been diagnosed with type 2 diabetes. - People who have been on a stable diabetes treatment plan for at least 3 months before the screening visit — this includes diet and exercise alone, or certain diabetes medications (note: some specific diabetes drug types are n...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 NCT07481630 · Novo Nordisk A/S Phase 3 · 10 countries Recruiting
Recruiting Phase 3 Est. completion 14 August 2028
🇦🇺 AU🇧🇬 BG🇨🇦 CA🇩🇰 DK🇬🇷 GR🇮🇹 IT🇵🇱 PL🇪🇸 ES +2 more

**Who might be able to join this trial:** - People who were male or female at birth - People who are 18 years of age or older at the time of signing the consent form - People who have been diagnosed with knee osteoarthritis based on recognised medical criteria, with visible changes on X-ray showing moderate-level joint...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 NCT07503210 · Novo Nordisk A/S Phase 3 · 12 countries Recruiting
Recruiting Phase 3 Est. completion 6 June 2028
🇦🇷 AR🇦🇺 AU🇧🇪 BE🇧🇬 BG🇩🇰 DK🇫🇷 FR🇩🇪 DE🇮🇹 IT +4 more

Who might be able to join this trial: - People who are 18 years of age or older at the time of signing the consent form. - People of any sex assigned at birth. Who may not be able to join: - People whose blood sugar control levels (measured by a test called HbA1c) are at or above a certain threshold at the screening s...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 NCT07581431 · InSilico Medicine Hong Kong Limited Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 29 January 2027
🇦🇺 AU

**Who might be able to join this trial:** **For healthy participants (certain study groups):** - People aged 18 to under 65, or aged 65 to 80 (depending on which group of the study) - People with a body mass index (a measure of body weight relative to height) between 18.5 and 30, and a body weight of at least 50 kg fo...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT00289380 · Peking Union Medical College Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2040
🇨🇳 CN

Who might be able to join this trial: - People who are staying in hospital overnight - People whose diagnosis matches the specific conditions listed in the trial's cohort study protocol for cost effectiveness (confirm with trial site) Who may not be able to join: - People who were admitted to hospital through the emer...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT00428987 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDD... Not Applicable · 1 country Recruiting
Recruiting Not Applicable
🇺🇸 US

Who might be able to join this trial: - Adults over 18 who are obese, with a BMI above 30 - Adults over 18 who are overweight, with a BMI between 25 and 30 - Adults over 18 who are a healthy weight, with a BMI between 18.5 and 25 (these participants may be matched with others based on age, sex, and years of education)...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT00739362 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDD... Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 31 January 2027
🇺🇸 US

**Who might be able to join this trial:** - People with a Body Mass Index (BMI) of 25 or higher (this means being overweight or obese by standard medical measurement) - People aged between 18 and 60 years old - People who are right-handed - People whose weight has stayed roughly the same (within 5%) over the past 3 mo...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT01084967 · Shanghai Jiao Tong University School of Medicine Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2030
🇨🇳 CN

Who might be able to join this trial: - People with a body mass index (BMI) of 30 or higher (this is a standard measure of body weight relative to height) - People who are predominantly from east China, as the trial is designed to limit differences in population background - People who are willing and able to give thei...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT01129297 · University Hospital, Lille Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2027
🇫🇷 FR

Who might be able to join this trial: - You are between 18 and 65 years old - You are scheduled for abdominal surgery, either open surgery (laparotomy) or keyhole surgery (laparoscopy), for weight-loss surgery, gallbladder removal, or abdominal wall repair - You have a Body Mass Index (BMI) of 35 or above AND have been...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT01224886 · University of Lausanne Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2028
🇨🇭 CH

Who might be able to join this trial: - People between the ages of 60 and 80 - People who are either very inactive (sedentary) or highly physically active and trained - People with a body mass index (a measure of body weight relative to height) between 18 and 40 - People who do not smoke - People whose blood sugar leve...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT01344525 · University of Hohenheim Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2029
🇩🇪 DE

Who might be able to join this trial: - Adults between 18 and 65 years old at the time of joining the trial - People with obesity, defined as having a Body Mass Index (BMI) greater than 30 kg/m² (a standard measure of body weight relative to height) - People who have undergone an obesity treatment — either a structured...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT01399385 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDD... Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 6 November 2028
🇺🇸 US

**Who might be able to join this trial:** - People with a history of heart or blood vessel disease, or those suspected of having it based on clinical findings or imaging tests such as ultrasound or specialised scans - People who have risk factors for hardening of the arteries (atherosclerosis), such as smoking, obesit...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT01736748 · St. Justine's Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2030
🇨🇦 CA

Who might be able to join this trial: - Children between 6 and 18 years old whose body weight falls above the 95th percentile for their age and sex on standard growth charts Who may not be able to join: - Children who have a physical or mental health condition that would make it difficult for them to take part in phys...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT01869530 · The Hospital for Sick Children Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2030
🇨🇦 CA

Who might be able to join this trial: - Children from birth up to (but not including) 6 years of age may be eligible. - A parent or guardian must be willing and able to give their consent for the child to take part. - The child must attend a doctor's practice that is part of the TARGet Kids! research network. Who may...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02208141 · University of Leipzig Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2030
🇩🇪 DE

Who might be able to join this trial: - People who weigh between 3,000 grams (about 3 kg, or roughly 6.6 lbs) and 180 kg (about 397 lbs) - People who are having a type of surgery that is considered suitable for this trial (confirm with trial site) - People who have signed a consent form agreeing to take part — if the p...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02273297 · University of Colorado, Denver Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2026
🇺🇸 US

"Who might be able to join this trial: - You must be a pregnant woman or an infant. - Your pregnancy must be less than 23 weeks along. - You must live in Colorado. Who may not be able to join: - You are expecting more than one baby (such as twins or triplets). - You had cancer before becoming pregnant. - You had a psy...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02583646 · National Institute of Environmental Health Sciences (NIEHS) Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2026
🇺🇸 US

**Who might be able to join this trial:** - Girls who do not have a long-term or ongoing medical condition - Girls whose body weight falls in the normal range (BMI between the 5th and 85th percentile for their age) or who are overweight or obese (BMI above the 85th percentile for their age) - Girls between 8 and 14 yea...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02646475 · Vanderbilt University Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 1 December 2029
🇺🇸 US

**Who might be able to join this trial:** - People aged 18 to 60 years of any race or gender - People with obesity, defined as a body mass index (BMI) between 30 and 40 kg/m² - People with insulin resistance, measured by a specific blood test score (called HOMA2-IR) greater than 2.2 - People with high blood pressure, e...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT02674230 · Chang Gung Memorial Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2035
🇹🇼 TW

Who might be able to join this trial: - People who are 20 years of age or older - People with a body mass index (BMI, a measure of body weight relative to height) of 24 or above - For participants in the normal/control group, people with a BMI below 24 Who may not be able to join: - People who have not given their inf...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02769975 · Eunice Kennedy Shriver National Institute of Child Health and Human De... Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2030
🇺🇸 US

Who might be able to join this trial: - Children and young people between 3 months and 18 years old who have a known or suspected hormone-related (endocrine) disorder may be eligible to participate. - Family members between 3 months and 100 years old may be enrolled if their participation would help doctors diagnose a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03008525 · Assistance Publique Hopitaux De Marseille Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 13 September 2025
🇫🇷 FR

Who might be able to join this trial: - People with a BMI greater than 35 kg/m² (classified as the obese group) or a BMI less than 30 kg/m² (classified as the non-obese group) - People who are scheduled to have bariatric (weight-loss) surgery (obese group) or another type of abdominal surgery (non-obese group) Who may...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03022682 · University of California, San Francisco Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇺🇸 US

**Who might be able to join this trial:** - People between the ages of 18 and 75 who are generally healthy - People who have been diagnosed with type 2 diabetes or metabolic syndrome (a group of conditions including high blood pressure, high blood sugar, and excess body fat around the waist) **Who may not be able to...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03288207 · National Heart, Lung, and Blood Institute (NHLBI) Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 4 August 2026
🇺🇸 US

**Who might be able to join this trial:** - African American women between the ages of 21 and 75 years old - Women who are overweight or obese, meaning a Body Mass Index (BMI) of 25 or higher - Women who live in Washington, DC Wards 5, 7, or 8, or in nearby parts of Prince George's County, Maryland - Women who own a sm...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03298334 · National Institute of Allergy and Infectious Diseases (NIAID) Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 April 2027
🇺🇸 US

**Who might be able to join this trial:** **For the mother:** - A planned caesarean delivery at 37 weeks of pregnancy or later - Carrying a single baby, in good general health, and aged 18 or older - Tested negative for infections that can be passed through bodily fluids, as part of standard early pregnancy care - Tes...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT03331133 · Guangzhou Women and Children's Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇨🇳 CN

Who might be able to join this trial: - Twin babies born at Guangzhou Women and Children's Medical Center - Families who live permanently in Guangzhou, or who plan to stay in Guangzhou with their children for at least 3 years - Families for whom pregnancy health information was recorded before the birth Who may not be...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03418857 · Penn State University Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 October 2022
🇺🇸 US

**Who might be able to join this trial:** - People with a body mass index (BMI) between 25 and 35 (a measure of body weight relative to height that falls in the overweight to moderately obese range) - People with a larger-than-average waist size — at least 94 cm for men or at least 80 cm for women - People who also hav...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT03440177 · Norwegian University of Science and Technology Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇳🇴 NO

Who might be able to join this trial: - People who are planning to have gastric bypass or sleeve gastrectomy (types of weight loss surgery) at a hospital in Central Norway - People who are Norwegian citizens Who may not be able to join: - People who have previously had surgery where part of their digestive tract (the...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03448783 · Norwegian University of Science and Technology Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇳🇴 NO

Who might be able to join this trial: - People who are planning to have gastric bypass or sleeve gastrectomy (types of weight-loss stomach surgery) at a hospital in Central Norway - People who are Norwegian citizens Who may not be able to join: - People who have previously had surgery where part of their digestive tra...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03460314 · Norwegian University of Science and Technology Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2026
🇳🇴 NO

Who might be able to join this trial: - You are planning to have gastric bypass or sleeve gastrectomy (types of weight loss surgery) in Central Norway - You are a Norwegian citizen Who may not be able to join: - You have previously had surgery where part of your digestive tract (stomach or intestines) was removed Imp...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03460379 · Norwegian University of Science and Technology Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2026
🇳🇴 NO

Who might be able to join this trial: - People who are planning to have gastric bypass or sleeve gastrectomy (types of weight loss surgery) at a hospital in Central Norway - People who are Norwegian citizens Who may not be able to join: - People who have previously had surgery where part of their digestive tract (stom...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03476538 · Norwegian University of Science and Technology Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2026
🇳🇴 NO

Who might be able to join this trial: - People who are planning to have gastric bypass or sleeve gastrectomy (types of weight-loss stomach surgery) at a hospital in Central Norway - People who are Norwegian citizens Who may not be able to join: - People who have previously had surgery where part of their digestive tra...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03476551 · Norwegian University of Science and Technology Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2026
🇳🇴 NO

Who might be able to join this trial: - People who are planning to have a gastric bypass or sleeve gastrectomy (weight loss surgery) at a hospital in Central Norway - People who are Norwegian citizens Who may not be able to join: - People who have previously had surgery where part of their digestive tract (stomach or...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03476577 · Norwegian University of Science and Technology Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2026
🇳🇴 NO

Who might be able to join this trial: - People who are planning to have a gastric bypass or sleeve gastrectomy (types of weight loss surgery) at a hospital in Central Norway - People who are Norwegian citizens Who may not be able to join: - People who have previously had surgery where part of their digestive tract (th...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03481829 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDD... Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2041
🇺🇸 US

Who might be able to join this trial: - Pregnant women aged 18 years or older, with pregnancy confirmed by a urine or blood test, or ultrasound. - Women who identify as American Indian or Hispanic. - Women who are willing to continue taking part in the study (both themselves and their child or children) for at least 3...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03497143 · Norwegian University of Science and Technology Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2026
🇳🇴 NO

Who might be able to join this trial: - People who are planning to have a gastric bypass or sleeve gastrectomy (types of weight-loss stomach surgery) at a hospital in Central Norway - People who are Norwegian citizens Who may not be able to join: - People who have previously had surgery where part of their digestive t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03514602 · State University of New York at Buffalo Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇺🇸 US

**Who might be able to join this trial:** - People who can read, understand, and speak English - People who are between 18 and 39 years old - People who are less than 20 weeks pregnant at the time of joining - People who are carrying a single baby (not twins or more) - People who are currently smoking at least one cig...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03516968 · Hospices Civils de Lyon Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 March 2027
🇫🇷 FR

**Who might be able to join this trial:** - Children and teenagers between 5 and 18 years old - Those who are obese, meaning their body weight measurement (BMI) is above the 97th percentile for their age and gender, based on World Health Organization growth charts - A parent or guardian has given formal written consent...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT03517072 · University Hospital, Lille Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2027
🇫🇷 FR

Who might be able to join this trial: - People who had bariatric (weight loss) surgery exactly 5 years ago. Who may not be able to join: - People who do not wish to take part in the study. - People who are unable to receive or understand the information needed to make an informed decision about joining (confirm with t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03519906 · Norwegian University of Science and Technology Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2026
🇳🇴 NO

Who might be able to join this trial: - You are planning to have a gastric bypass or sleeve gastrectomy (types of weight loss surgery) at a hospital in Central Norway - You are a Norwegian citizen Who may not be able to join: - You have previously had surgery where part of your digestive tract (such as your stomach or...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03535376 · Norwegian University of Science and Technology Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2026
🇳🇴 NO

Who might be able to join this trial: - People who are planning to have gastric bypass or sleeve gastrectomy (weight loss surgeries) at a hospital in Central Norway - People who are Norwegian citizens Who may not be able to join: - People who have previously had surgery where part of their digestive tract (stomach or...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03538457 · Norwegian University of Science and Technology Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2026
🇳🇴 NO

Who might be able to join this trial: - People who are planning to have a gastric bypass or sleeve gastrectomy (weight loss surgery) at a hospital in Central Norway - People who are Norwegian citizens Who may not be able to join: - People who have previously had surgery to remove part of their digestive tract (such as...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03554902 · IHU Strasbourg Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2028
🇫🇷 FR

Who might be able to join this trial: - People who are scheduled to have a surgical procedure called endoscopic gastric tubulization (a stomach-shaping procedure) at the Nouvel Hôpital Civil hospital in Strasbourg, France Who may not be able to join: - No specific exclusion criteria were listed in the official trial i...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03561766 · Shengjing Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2020
🇨🇳 CN

**Who might be able to join this trial:** - Women who are pregnant and less than 13 weeks along in their pregnancy - People who are permanent residents or whose families plan to stay in Shenyang and the surrounding areas - Women who are planning to have their pregnancy check-ups and give birth at Shengjing Hospital **...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03574103 · Federal University of Minas Gerais Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2025
🇧🇷 BR

**Who might be able to join this trial:** - People who are female - People aged between 18 and 59 years old - People with a body mass index (BMI) of 25 kg/m² or higher (this means being classified as overweight or above — confirm with trial site if unsure of your BMI) - People who are willing to read and sign a consent...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03633162 · Guangzhou Women and Children's Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇨🇳 CN

Who might be able to join this trial: - People who were born at Guangzhou Women and Children's Medical Center and whose maternal grandmother's daughter (their mother) gave birth there - People whose maternal grandmother's daughter (their mother) has pregnancy health information available from that time Who may not be...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03663530 · Columbia University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 July 2026
🇺🇸 US

**Who might be able to join this trial:** - People of any racial or ethnic background - People with a body mass index (a measure of height-to-weight ratio) between 20 and 34.9 - People who sleep an average of 7 hours or more per night, as measured over a 2-week screening period - People who eat something within 1 hour...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03756961 · Göteborg University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 May 2028
🇸🇪 SE

Who might be able to join this trial: - Adults aged 18 or older who are scheduled to have laparoscopic weight-loss surgery (gastric bypass or sleeve surgery) at the participating hospital. Who may not be able to join: - People whose overall health before surgery is rated as very poor (above a certain medical risk leve...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03868592 · Mayo Clinic Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2027
🇺🇸 US

Who might be able to join this trial: - People with a Body Mass Index (BMI) between 40 and 50 kg/m² (a measure of body weight relative to height). - People without any active physical illness that would interfere with movement or weight loss following bariatric (weight loss) surgery. Who may not be able to join: - Peo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04036331 · Wake Forest University Health Sciences Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2026
🇺🇸 US

Who might be able to join this trial: - People who are eligible to enroll in the Brenner FIT and/or By Design Essentials programs (confirm with trial site) - A caregiver who lives in the same home as the child and has a Body Mass Index (BMI) over 30 (BMI is a number calculated from height and weight) - People who have...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04046562 · Connecticut Children's Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2027
🇺🇸 US

Who might be able to join this trial: - People between 12 and 18 years of age (male or female) - People who can speak, read, and write in English - People who have a parent or guardian who can speak, read, and write in English - People whose parent or guardian has signed a consent form, and who have themselves agreed t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04087655 · Florida State University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 19 November 2026
🇺🇸 US

**Who might be able to join this trial:** - People of any race, sex, or socioeconomic background may be considered. - Women who have not yet reached menopause may be eligible. - Women who are currently using a combined estrogen and progestin hormonal contraceptive (such as the pill, a skin patch, or a vaginal ring) ma...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04136717 · François Lellouche Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2027
🇨🇦 CA

**Who might be able to join this trial:** **For people with a flare-up of a chronic lung condition (AECOPD):** - People whose blood tests during their hospital stay show that carbon dioxide levels are too high and the blood has become too acidic, whether or not they are already using a breathing support mask - People...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04242069 · Université de Sherbrooke Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2025
🇨🇦 CA

Who might be able to join this trial: - Couples (a woman and her partner) who are trying to conceive within 12 months of joining the trial - The woman in the couple has a body mass index (a measure of weight relative to height) of 25 or above, which is generally considered overweight or obese - The woman has access to...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04293224 · USDA, Western Human Nutrition Research Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2026
🇺🇸 US

**Who might be able to join this trial:** - People with a Body Mass Index (BMI) between 23 and 39.9, or a body fat percentage between 32% and 50%. - People who are willing to have blood drawn as part of the study. - People who also have at least one of the following: a fasting blood sugar level between 100 and 125 mg/...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04298125 · Arkansas Children's Hospital Research Institute Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇺🇸 US

Who might be able to join this trial: - People with a Body Mass Index (BMI) over 30 (a measure of body weight relative to height) - People who are pregnant with one baby (not twins or more) - People who are between 11 and 15 weeks pregnant at the time of joining the trial - People who are currently getting less than 15...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04320264 · East Carolina University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇺🇸 US

Who might be able to join this trial: - People who are between 18 and 50 years old - People with a body mass index (a measure of body weight relative to height) between 25 and 30, or above 40 - People whose blood lactate levels (a substance produced by the body during physical activity) fall in either the top 25% or bo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04394806 · University of Colorado, Denver Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2027
🇺🇸 US

Who might be able to join this trial: - Women who are pregnant and less than 16 weeks along in their pregnancy - People between the ages of 21 and 39 years old - People whose body weight before pregnancy fell into a specific range (a BMI between 28 and 39, which generally means overweight to moderately obese — confirm...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04453072 · Jonsson Comprehensive Cancer Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇺🇸 US

**Who might be able to join this trial:** - People who have had any type of stem cell transplant (HSCT) and are at least 100 days past their transplant date at the time of their first study visit - People whose body mass index (BMI) is at or above the 85th percentile for their age and gender (a measure that places the...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04471506 · Cairo University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2024
🇪🇬 EG

**Who might be able to join this trial:** - Women who are postmenopausal and between 55 and 65 years old - Women with a Body Mass Index (BMI) — a measure of body weight relative to height — between 35 and 39.9 - Women who have been postmenopausal for more than 2 years **Who may not be able to join:** - Women who are c...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04491344 · University of Leipzig Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2030
🇩🇪 DE

"Who might be able to join this trial: - Children and young people who are seen at the obesity/weight management outpatient clinic - A signed consent form agreeing to take part in the study must be in place Who may not be able to join: - There are no listed exclusion criteria for this trial — the trial site will be be...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04526743 · GOSEEN Obesity group of the Spanish Endocrinology Society Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2021
🇪🇸 ES

Who might be able to join this trial: - People who were scheduled to have their first bariatric (weight loss) surgery between September 2020 and September 2021 - People with severe obesity (a body mass index over 40) who are not suitable candidates for weight loss surgery - People who use the internet regularly - The t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04551482 · Massachusetts General Hospital Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 31 December 2026
🇺🇸 US

Who might be able to join this trial: - People aged 10 to 18 years, of any gender - People with obesity, meaning a BMI at or above the 95th percentile for their age and gender - People who are willing to keep their current diet and lifestyle the same for the whole time they are in the study Who may not be able to join...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT04583514 · Pennington Biomedical Research Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇺🇸 US

**Who might be able to join this trial:** - You are a man or a woman who has not yet gone through menopause - You are between 18 and 42 years old - Your body mass index (a measure of body weight relative to height) falls roughly between 23 and 35 - You are willing to drink a special type of water (called deuterium-labe...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04603859 · University of Aarhus Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2026
🇩🇰 DK

**Who might be able to join this trial:** - Pregnant women who had a BMI of 30 or higher before pregnancy or in early pregnancy **Who may not be able to join:** - People who are under 18 years of age - People who need an interpreter or translator due to language difficulties - People carrying more than one baby (e.g.,...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04613583 · University of Aberdeen Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2028
🇬🇧 GB

Who might be able to join this trial: - Women who are between 7 and 20 weeks pregnant at the time of joining. - Women who are 16 years of age or older and considered able to make an informed decision. - Women whose ultrasound scan has shown no abnormalities with the baby. - Women who speak fluent English, so they can f...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04613791 · Centre Hospitalier Universitaire de Nīmes Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 December 2026
🇫🇷 FR

**Who might be able to join this trial:** - You are being seen for the first time at the Nîmes University Hospital Obesity Clinic (whether as an inpatient, outpatient, or for a consultation). - You are being treated for obesity, meaning your Body Mass Index (BMI) is 30 or above. - You are covered by a health insurance...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04614961 · Universitaire Ziekenhuizen KU Leuven Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2099
🇧🇪 BE

"Who might be able to join this trial: - People who have given their signed consent to take part in the study - People who are 18 years of age or older - People who are overweight, living with obesity, or who have previously had bariatric (weight-loss) surgery Who may not be able to join: - No specific exclusion crite...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04661449 · Xinhua Hospital, Shanghai Jiao Tong University School of Medicine Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 November 2023
🇨🇳 CN

**Who might be able to join this trial:** - Babies born at full term (not premature) - Babies who were larger than average for their stage of pregnancy at birth **Who may not be able to join:** - Babies diagnosed with a significant genetic condition - Babies born with physical abnormalities that were present from birt...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04748770 · Centre Hospitalier Universitaire, Amiens Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇫🇷 FR

Who might be able to join this trial: - People who are 18 years of age or older. - People with a body mass index (BMI) of 30 or higher (for the main study group), or a BMI between 25 and 30 (for the comparison group), measured one month after starting dialysis treatment. - People who have agreed to allow their health d...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04752293 · Wake Forest University Health Sciences Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇺🇸 US

**Who might be able to join this trial:** This trial has two separate groups — one for children and teenagers with high blood pressure (hypertension), and one for those with normal blood pressure (the comparison group). Criteria are listed for each. --- **HYPERTENSION GROUP** Who might be able to join this trial: -...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04755062 · Northern Arizona University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2025
🇺🇸 US

Who might be able to join this trial: - People who identify as Native American and work as an employee at Twin Arrows Casino - People between 21 and 65 years of age - People with a self-reported Body Mass Index (BMI) — a measure of body weight relative to height — above 24 kg/m² (confirm with trial site for how this is...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04824248 · Vrije Universiteit Brussel Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇧🇪 BE🇳🇱 NL

**Who might be able to join this trial:** - People who are overweight (BMI of 25 or above) or obese (BMI of 30 or above) and have chronic low back pain - People who have had general, non-specific low back pain for at least 3 months - People who are currently seeing someone for their low back pain - People whose first l...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04838249 · University of Leipzig Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2026
🇩🇪 DE

**Who might be able to join this trial:** - People who are transgender and are currently receiving cross-sex hormone therapy, or people who are acting as a comparison group (controls) - People who are able to give informed consent; if the person is under 18 years old, all legal guardians must also give consent - For o...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04851470 · Queen Mary University of London Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇬🇧 GB

Who might be able to join this trial: - People who are over 18 years of age. - People who have a Body Mass Index (BMI) of 30 or higher (this is a standard measure of body weight relative to height). - People who have voluntarily signed a written consent form agreeing to take part. Who may not be able to join: - People...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04873258 · Richmond Research Institute Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇬🇧 GB

**Who might be able to join this trial:** - People aged 18 to 80 years old at the time of signing the consent form, either male or female - People who are willing and able to sign and date a written consent form agreeing to take part - People who are able and willing to follow all of the trial's procedures and require...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04894838 · St. Antonius Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2029
🇳🇱 NL

Who might be able to join this trial: - People aged between 18 and 65 years old - People with a body mass index (BMI) of 40 or above, or a BMI of 35 or above combined with a health condition related to obesity - People who have previously had a type of weight loss surgery called Roux-en-Y gastric bypass (RYGB) but have...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04913064 · City of Hope Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 12 January 2027
🇺🇸 US

**Who might be able to join this trial:** - You are a woman who has gone through menopause (no periods for 12+ months, or you've had both ovaries or your uterus removed, confirmed by hormone levels if needed) - You are 21 years of age or older - You have a body mass index (BMI) of 30 or higher (or 25 or higher if you...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04917601 · Karolinska Institutet Not Applicable · 4 countries Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
🇮🇹 IT🇳🇴 NO🇵🇱 PL🇸🇪 SE

**Who might be able to join this trial:** - Children and young people who are older than 4 years and younger than 17 years old at the time of joining - Those whose body weight falls within a specific obesity range (based on international guidelines, with a standardised BMI score between 30 and 40) — not severely obese...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04934228 · University of Kansas Medical Center Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 1 August 2026
🇺🇸 US

**Who might be able to join this trial:** - People aged between 18 and 79 years old, of any gender - People with a BMI (body mass index) over 30, which is generally considered obese - People with high blood pressure, specifically a reading above 130/80 - People with elevated insulin resistance, measured by a specific b...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT04942093 · University Hospital, Rouen Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 20 November 2026
🇫🇷 FR

**Who might be able to join this trial:** - People who have been approved for bariatric (weight loss) surgery and are scheduled to have a sleeve gastrectomy (a procedure that reduces the size of the stomach) - People with a BMI of 40 or higher (classified as morbid obesity) - People aged 18 to 65 years old - People wh...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04997473 · University of California, Los Angeles Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 9 January 2027
🇺🇸 US

**Who might be able to join this trial:** - You are between 13 and 30 years old (inclusive) - You have had a stem cell transplant (any type) and it has been at least 100 days since your transplant at the time of your first study visit - You are male or female - Your BMI (a measure of body weight relative to height) is...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05028205 · The University of Tennessee, Knoxville Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 2 December 2026
🇺🇸 US

Who might be able to join this trial: - The child must be a patient at the Cherokee Health Systems clinic in Cherokee Mills. - The child must be between 4 and 10 years old. - The child must have a Body Mass Index (BMI) — a measure of body weight relative to height — above the 85th percentile for their age group (confir...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05051436 · Philip Kern Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 August 2026
🇺🇸 US

Who might be able to join this trial: - People whose HbA1c blood sugar level falls between 5.7 and 6.4 (a range sometimes called "prediabetes") - People whose body mass index (a measure of body weight relative to height) falls between 27 and 45 Who may not be able to join: - People who have diabetes - People who regul...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT05053113 · M.D. Anderson Cancer Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 2 February 2027
🇺🇸 US

**Who might be able to join this trial:** - People who identify as female - People aged between 18 and 65 years old - People who speak English or Spanish - People who are physically able to do light to moderate exercise, either based on a standard readiness questionnaire or with approval from a doctor - People who cur...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05067231 · University of Alabama at Birmingham Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2030
🇺🇸 US

Who might be able to join this trial: - People who are 18 years of age or older Who may not be able to join: - People who are under 18 years of age at the time of screening - People who work or study within the Division of Cardiovascular Disease at UAB (University of Alabama at Birmingham), as their connection to the...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05077579 · Cyrus A Raji Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2027
🇺🇸 US

**Who might be able to join this trial:** - You are between 40 and 60 years old, of any gender or race - You have a normal or near-normal memory and thinking score on a standard screening test (confirm with trial site) - You are willing and able to have MRI scans - You are willing to have PET scans that involve inject...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05119868 · Federico II University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 10 January 2025
🇮🇹 IT

Who might be able to join this trial: - Women aged 20 to 35 years old who are healthy and in their first trimester of pregnancy - Women whose baby is considered at risk of developing allergic conditions (atopy) Who may not be able to join: - People who currently have an active infection - People who currently have any...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05125822 · Ann & Robert H Lurie Children's Hospital of Chicago Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2028
🇺🇸 US

Who might be able to join this trial: - People who are between 11 and under 16 years old - People with a BMI above 30 kg/m² or at or above the 95th percentile for BMI (a measure used to assess body weight relative to height and age) - People at a mid-stage of puberty development, known as Tanner stage 2, 3, or 4 (confi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05147909 · University of Texas Southwestern Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 March 2027
🇺🇸 US

**Who might be able to join this trial:** - People who are generally healthy, without diabetes, kidney disease, heart or blood vessel disease, or any current use of medications that affect blood pressure or circulation **Who may not be able to join:** - People who have a history of heart or lung disease, or chronic ki...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05173714 · Srinvasan Beddhu Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 31 December 2026
🇺🇸 US

**Who might be able to join this trial:** - Your kidneys are working at a reduced but not severely low level — specifically, a kidney function score (eGFR) between 20 and less than 60 (confirm with trial site if unsure of your score) - You are physically able to do resistance/strength training exercises - You have acce...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05199454 · University of Illinois at Chicago Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇺🇸 US

Who might be able to join this trial: - People with a Body Mass Index (BMI) of 35 or higher (a measure of body weight relative to height) - People between the ages of 18 and 50 - People who are not pregnant - People who have diabetes, meaning those currently taking diabetes medication or who have a fasting blood sugar...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05202353 · Boehringer Ingelheim Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 2 December 2026
🇳🇱 NL

**Who might be able to join this trial:** - You have been assessed as generally healthy by a doctor, based on a full health check including physical exam, blood pressure, heart rate, heart tracing (ECG), and blood tests - You are between 18 and 65 years old (inclusive) - Your Body Mass Index (BMI) is between 30 and 40,...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05207059 · KK Women's and Children's Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
🇸🇬 SG

**Who might be able to join this trial:** - Women between 21 and 40 years of age - People with a body mass index (BMI) between 25 and 40 (a measure of body weight relative to height) - People who plan to stay living in Singapore for the next 4 years - People who are Chinese, Malay, Indian, or any combination of these t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05216042 · University of Alabama at Birmingham Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2026
🇺🇸 US

**Who might be able to join this trial:** - Adults aged 18 or older (the trial aims to enrol equal numbers of men and women) - People who agree to provide a genetic material sample (such as a blood or saliva sample for DNA testing) - People who are willing to follow all the requirements of the study protocol throughout...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05235945 · University College, London Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2025
🇬🇧 GB

Who might be able to join this trial: - Adults aged 18 or older. - People who are enrolled in the bariatric (weight loss) surgery program at UCLH, Homerton, or Whittington Hospitals, with a BMI over 30 kg/m². - People whose body weight has stayed within 5% of the same level over the past 3 months (meaning their weight...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05237440 · University Hospital, Limoges Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 13 May 2027
🇫🇷 FR

**Who might be able to join this trial:** - Women aged 18 or older - Women with a Body Mass Index (BMI) of 30 or above (this is the medical measure used to classify obesity) **Who may not be able to join:** - People who have previously had weight-loss (bariatric) surgery - People who are currently pregnant or breastfe...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05242835 · Laval University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2027
🇨🇦 CA

Who might be able to join this trial: - People who had a sleeve gastrectomy (a type of weight-loss stomach surgery) at least 18 months ago. - People whose body weight still meets the standard guidelines for weight-loss surgery — either a BMI of 35 or above with serious weight-related health conditions, or a BMI of 40 o...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05277714 · Rennes University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2026
🇫🇷 FR

**Who might be able to join this trial:** - You have a body mass index (BMI) of 40 or higher, or a BMI of 35 or higher with other weight-related health conditions, and have been assessed as suitable for weight-loss surgery under French health guidelines - You are right-handed - You have been identified as having a food...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05281016 · KK Women's and Children's Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇸🇬 SG

Who might be able to join this trial: - Children between 6 and 12 years old - Children whose BMI (a measure of body weight relative to height) falls above the 90th percentile for their age, which is considered overweight - Children (and their parent or carer) who are able to give informed consent to participate Who ma...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05289310 · Pennington Biomedical Research Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 October 2026
🇺🇸 US

Who might be able to join this trial: - People with a body mass index (BMI) between 30 and 39.9, which falls in the obese range - People who were born at altitudes below 2,100 meters (about 7,000 feet) above sea level - People who currently live in Tallahassee, Florida or the surrounding area - People who have complete...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05301413 · University of Missouri, Kansas City Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 31 December 2025
🇺🇸 US

Who might be able to join this trial: - People who identify as Black or African American - People who are overweight, meaning a Body Mass Index (BMI) above 24 (a measure of body weight relative to height) - People who have been diagnosed with prediabetes, previously diagnosed with gestational diabetes (diabetes during...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05309395 · Kaiser Permanente Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 June 2026
🇺🇸 US

Who might be able to join this trial: - The household must be a Latino family with members from at least two generations living together (for example, children under 18 and adults, or adults and older relatives aged 65+), with between 3 and 5 people living in the home - At least two adults in the household must have a...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05316493 · Xiaojun Chen Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 28 February 2026
🇨🇳 CN

Who might be able to join this trial: - People aged between 18 and 45 years old - People with a body mass index (BMI) of 24 or higher (a measure of body weight relative to height) - People who have given written, informed consent to participate - People who have been confirmed by tissue testing to have a condition call...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05353504 · Max Planck Institute for Human Cognitive and Brain Sciences Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2024
🇩🇪 DE

Who might be able to join this trial: - People with a body mass index (BMI) of 25 or higher, or a waist-to-hip ratio above certain measurements that indicate excess abdominal fat (confirm with trial site for exact measurements) - People who are able to safely have an MRI scan (no metal implants or other reasons that wo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05356000 · University of Chicago Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 2 June 2026
🇺🇸 US

**Who might be able to join this trial:** *People who have had Roux-en-Y gastric bypass surgery:* - Adults aged 18 to 70 who have previously had a type of weight-loss surgery called Roux-en-Y gastric bypass - People who have had at least one calcium-based kidney stone after that surgery - People whose urine oxalate le...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05364957 · University Hospital, Toulouse Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2029
🇫🇷 FR

Who might be able to join this trial: - Adults between 18 and 65 years old, of any gender - People who have been diagnosed with asthma according to recognised international guidelines - People whose asthma is not well controlled (based on a specific asthma control score) even while using inhaled steroid medicines, with...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05432362 · Medical University of Graz Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 January 2026
🇦🇹 AT

**Who might be able to join this trial:** - People who identify as female and are between 18 and 40 years old - People who have received full information about the trial's aims, methods, expected benefits, possible risks, and any discomforts involved, and have signed a consent form - People in the depression group: th...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05464186 · Boston Children's Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇺🇸 US

Who might be able to join this trial: - Children who are between 9 and 12 years old - Children whose BMI (a measure of body weight relative to height) is at or above the 75th percentile for their age and sex - Children who live in the Greater Boston area Who may not be able to join: - Children who dislike or refuse to...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05468437 · Santa Clara Valley Health & Hospital System Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2026
🇺🇸 US

**Who might be able to join this trial:** - People who have had a traumatic spinal cord injury - People who are at least 1 year past the date of their injury - People who are 20 years of age or older - People with a BMI greater than 22 kg/m² at the time of enrollment - People who speak and understand English or Spanis...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05476627 · Peking Union Medical College Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2025
🇨🇳 CN

**Who might be able to join this trial:** - People who have been diagnosed with a metabolic disease. - People who are able to understand what the research involves. - People who are willing to take part and able to sign a consent form. **Who may not be able to join:** - People who are under 18 years old or over 80 yea...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05498675 · Beijing Friendship Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇨🇳 CN

**Who might be able to join this trial:** - You have been diagnosed with high blood pressure that has no known underlying cause (also called essential hypertension) - You are between 18 and 70 years old - You are able to read, understand, and sign a consent form agreeing to take part **Who may not be able to join:** -...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05514288 · Cedars-Sinai Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2025
🇺🇸 US

Who might be able to join this trial: - People who are thinking about having Endoscopic Bariatric Therapy (EBT) for weight loss - People with a Body Mass Index (BMI) over 30, without any weight-related health conditions - People with a BMI over 27, who also have health conditions related to their weight - People who ar...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05521490 · The University of Hong Kong Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2026
Hong Kong

**Who might be able to join this trial:** - Children who are 5–6 years old (a limited number of children aged 4–5 or 6–7 may also be considered) - Children who are able to communicate in Chinese - Children who are able to take part in physical activity in a standard kindergarten environment **Who may not be able to jo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05530538 · University of California, Los Angeles Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇺🇸 US

**Who might be able to join this trial:** - People aged 14 to 21 years old - People who own an iPhone or are willing to use one provided by the study - People who can read and speak English - People who answer in a specific way on a short 5-question survey about motivation to manage their weight — for example, people w...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05545306 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDD... Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 2 February 2027
🇺🇸 US

**Who might be able to join this trial:** - People between 18 and 60 years old (male or female) - People who have not intentionally tried to lose weight in the past 6 months **Who may not be able to join:** - People who use tobacco products at a level above "Very Low Dependence" on a standard nicotine dependence scale...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05585190 · Medical College of Wisconsin Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇺🇸 US

**Who might be able to join this trial:** - People who are overweight or obese (a body mass index of 25 or higher) - People who work in a desk-based job where at least 75% of their workday (8 hours or more) is spent sitting, whether at home or in an office - People who are considered "at risk" for diabetes, which mean...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05589688 · University Hospital, Toulouse Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 1 December 2026
🇫🇷 FR

**Who might be able to join this trial:** - Healthy volunteers with a BMI between 18 and 39.9 (the trial is looking for people across four weight ranges: normal weight, overweight, grade 1 obesity, and grade 2 obesity) - People whose kidneys are working at a sufficient level (a kidney function score above 50 ml/min, as...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05606731 · University of California, Los Angeles Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2026
🇺🇸 US

**Who might be able to join this trial:** - Adults who identify as being of Latino heritage - People who are a caregiver (not necessarily a biological relative) for a child or grandchild between 2 and 5 years old who has been assessed as overweight or obese (with a body mass index above the 85th percentile for their a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05619705 · Johns Hopkins University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 December 2026
🇺🇸 US

Who might be able to join this trial: - People who are pregnant and at 33 weeks of pregnancy or earlier - People who are carrying one baby (not twins, triplets, etc.) - People whose body weight before pregnancy falls into the overweight or obese range (a BMI of 25 or higher, based on self-reported height and weight bef...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05623007 · Indonesia University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 April 2025
🇮🇩 ID

Who might be able to join this trial: - People who have been living permanently in Jakarta, Surabaya, or Yogyakarta City for at least 6 months - People who are generally healthy with no known illnesses - Male or female adolescents between the ages of 12 and 17 years old - People who are overweight or obese, based on a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05630482 · Penn State University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 July 2027
🇺🇸 US

Who might be able to join this trial: - You are a two-parent family where one or both parents are currently serving in the active duty military - You are expecting your first child and are no more than 7 months pregnant at the time of joining Who may not be able to join: - Either parent has an active diagnosis of canc...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05632406 · Florida State University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2027
🇺🇸 US

**Who might be able to join this trial:** - People with a body mass index (BMI) of 40 or below (BMI is a measure based on height and weight) **Who may not be able to join:** - People whose body weight has changed by 5% or more in the past six months - People with a known serious heart, neurological, kidney, liver, or...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05653258 · Cedars-Sinai Medical Center Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 February 2027
🇺🇸 US

**Who might be able to join this trial:** - People of any sex, race, or ethnic background who fall into one of three groups: adults aged 18–30 with a healthy weight (BMI 18.5–24.9), adults aged 18–30 with obesity (BMI 30–39.9), or adults aged 65 and older with obesity (BMI 30–39.9) - People who live independently in t...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05654337 · The New Model of Care, Hail Health Cluster Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2024
🇸🇦 SA

Who might be able to join this trial: - Adults between the ages of 18 and 60 who have been confirmed to have obesity or to be overweight Who may not be able to join: - People who are severely ill - People who have other long-term (chronic) health conditions Important: Always verify eligibility with the trial site dir...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05656807 · UNC Lineberger Comprehensive Cancer Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2026
🇺🇸 US

Who might be able to join this trial: **Child Care Centers:** - The center must be open all year round - The center must be licensed and have no plans to close within the next 2 years - The center must have been running for at least 1 year - The center must have at least two classrooms for children aged 2 to 5 years o...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05723679 · University of Texas Southwestern Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2028
🇺🇸 US

Who might be able to join this trial: - People who have signs and symptoms of heart failure - People whose heart is pumping at a rate greater than 50% of its normal capacity (known as an ejection fraction above 0.50) - People with measurable evidence that their heart muscle is not relaxing properly between beats (diast...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05726942 · San Diego State University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2028
🇺🇸 US

Who might be able to join this trial: - People between the ages of 18 and 64 - People with a Body Mass Index (BMI) of 25 or higher (BMI is a measure based on height and weight) - People who have a bathroom scale at home or can regularly access one - People who own a smartphone and are willing to download a mobile app f...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05744479 · Centre for Addiction and Mental Health Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 March 2027
🇨🇦 CA

**Who might be able to join this trial:** - People aged 16 to 65 years - People who are stable and being seen as outpatients (not currently admitted to hospital) - People who have been diagnosed with an intellectual or developmental disability (IDD) - People who have been taking an antipsychotic medication at a stable...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT05750732 · Hacettepe University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2025
Turkey (Türkiye)

**Who might be able to join this trial:** - People between 20 and 50 years of age - People in the study group with a body mass index (BMI) between 25 and 40 kg/m² (a measure of body weight relative to height that falls in the overweight to obese range) - People in the control group with a BMI between 18.5 and 24.9 kg/m...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05752799 · G.Gennimatas General Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 28 May 2026
🇬🇷 GR

**Who might be able to join this trial:** - You are between 18 and 75 years old - You have been officially diagnosed with morbid obesity (a high level of excess body weight that affects health) - You have been assessed as being in a moderate health risk category for surgery, known as ASA level II or III (confirm with t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05753124 · Chelsea and Westminster NHS Foundation Trust Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2027
🇬🇧 GB

Who might be able to join this trial: - Pregnant women with a body weight considered normal range (BMI under 30) - Pregnant women living with obesity (BMI of 30 or above) - Pregnant women who have a condition affecting how their body manages blood sugar (such as gestational diabetes or similar) - Pregnant women who hav...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05754645 · Erasmus Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 21 August 2025
🇳🇱 NL

Who might be able to join this trial: - People who are already taking part in the Predict study - Women who are planning to become pregnant or who are less than 13 weeks pregnant - People with a BMI (body mass index) either above 30 or between 18 and 25 - People who can speak and read Dutch - People who are willing to...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05770570 · Memorial Sloan Kettering Cancer Center Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 26 February 2027
🇺🇸 US

**Who might be able to join this trial:** This trial has several separate groups, each with different criteria. A person would need to meet the criteria for the specific group they are being considered for. **COMIDA group:** - People who identify as Mexican American or Mexican - People who are seeking services at the...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05772052 · Istituto Auxologico Italiano Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇮🇹 IT

Who might be able to join this trial: - People with a BMI (body mass index) between 30 and 45 kg/m² Who may not be able to join: - People who are unable or unwilling to cooperate with the trial requirements - People who smoke heavily - People who are pregnant or who have given birth in the last 6 months - People who h...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05777928 · Istituto Auxologico Italiano Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇮🇹 IT

**Who might be able to join this trial:** - People who meet the SICOB criteria (an Italian surgical society's standards) for sleeve gastrectomy, a type of weight-loss stomach surgery (confirm with trial site) - People who have previously had a sleeve gastrectomy or gastric bypass surgery and have regained weight, and w...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05783765 · University of Pennsylvania Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 October 2027
🇺🇸 US

Who might be able to join this trial: - Children who are generally healthy - Children who are between 5 and 7 years old - Children whose BMI is at or above the 5th percentile for their age - The child's biological mother must also be their primary caregiver and take part in the trial - The child's mother must be able t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05791604 · Children's Hospital of Fudan University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 March 2028
🇨🇳 CN

**Who might be able to join this trial:** - Children with Prader-Willi syndrome (before their teenage years) who have been confirmed to have the condition through genetic testing - Children who meet the medical definition of obesity - Children who are not currently taking part in, and have not taken part in, any other...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05798676 · Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernan... Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2028
🇦🇷 AR

Who might be able to join this trial: - Women who are currently breastfeeding and who had a normal, overweight, or obese body weight before becoming pregnant, based on World Health Organization definitions Who may not be able to join: - Women who have Type 1 diabetes, Type 2 diabetes, or diabetes that developed during...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05799846 · The Miriam Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 August 2027
🇺🇸 US

Who might be able to join this trial: - People who are between 18 and 70 years old - People with a BMI between 25 and 45 kg/m² (confirm with trial site if unsure about BMI) - People who have regular weekly access to the internet, either through a smartphone, or a home or work broadband/Wi-Fi connection Who may not be...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05806801 · University of Michigan Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2027
🇺🇸 US

**Who might be able to join this trial:** - People aged 18 to 40 years old - People with a Body Mass Index (BMI) between 30 and 40 (a measure of body weight relative to height) - People whose weight has been stable — changing by no more than 3kg — for at least approximately 2 months - People who do not have a regularly...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05807594 · Penn State University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 January 2028
🇺🇸 US

**Who might be able to join this trial:** - People who are currently pregnant - People who are between 8 and 18 weeks pregnant at the time of screening - People carrying a single baby (not twins, triplets, etc.) - People who smoke 20 or fewer cigarettes per day - People of any pregnancy history (first-time pregnancy o...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05811624 · Vrije Universiteit Brussel Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 1 April 2026
🇧🇪 BE🇨🇭 CH

**Who might be able to join this trial:** - You are between 18 and 65 years old. - You are overweight or obese, meaning your body mass index (BMI) is 25 or higher. - You have had general low back pain (not caused by a specific known condition) for at least 3 months and are currently seeking care for it. - Any leg pain...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05840497 · Fundacion Miguel Servet Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2025
🇪🇸 ES

Who might be able to join this trial: - People who are pregnant with one baby (not twins or more) - People with a BMI (body mass index) of 25 or higher at the time of the trial Who may not be able to join: - People who have high blood pressure that existed before or outside of pregnancy - People who had diabetes (type...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05843318 · Virginia Polytechnic Institute and State University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 20 December 2027
🇺🇸 US

**Who might be able to join this trial:** - People who are 50 years of age or older - People with a body mass index (BMI) of 25 or higher (this is a standard measure of body weight relative to height) - People whose weight has stayed roughly the same (within 2 kg) over the past 6 months - People who are willing to give...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05847478 · Children's Hospital of Fudan University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 November 2026
🇨🇳 CN

Who might be able to join this trial: - You have at least one of the following health conditions: being overweight or obese, having prediabetes, having abnormal cholesterol or fat levels in your blood, or having high blood pressure. - A Traditional Chinese Medicine practitioner has assessed you as having a specific pat...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05857150 · Mayo Clinic Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2029
🇺🇸 US

Who might be able to join this trial: - Adults who are obese and are between 20 and 45 years of age (both men and women) Who may not be able to join: - People who have diabetes or a fasting blood sugar level above 126 mg/dL - People with low red blood cell levels (anaemia) — specifically, women with a haemoglobin leve...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05861973 · Florida State University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 April 2027
🇺🇸 US

Who might be able to join this trial: - People who are over 18 years old - People with a BMI of 25 or higher and a body weight under 396 lbs - People who own a smartphone and are willing to install an app called SMARTer - People who are not currently enrolled in a formal weight loss program Who may not be able to join...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05933499 · Massachusetts General Hospital Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 31 December 2028
🇺🇸 US

**Who might be able to join this trial:** - People with a body mass index (BMI) of 30 or higher, or a BMI of 27 or higher if they also have at least one health condition related to their weight (such as high blood pressure or high cholesterol) - People who have tried at least once in the past to lose weight through di...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05935111 · Binghamton University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2024
🇺🇸 US

**Who might be able to join this trial:** - People who are between 18 and 64 years old - People with a Body Mass Index (BMI) of 25 or higher (BMI is a number calculated from height and weight — the trial site can help clarify this) - People who have access to a device such as a computer or smartphone that can open a we...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05942287 · University of Oxford Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
Jersey🇬🇧 GB

Who might be able to join this trial: - People diagnosed with heart failure where the heart is pumping at a reduced level (specifically, where the heart pumps out between 20% and 45% of blood with each beat) - People with a body mass index (a measure of body weight relative to height) above 27.5 kg/m² Who may not be a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05956574 · Augusta University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇺🇸 US

Who might be able to join this trial: - People between 18 and 40 years old - People with a Body Mass Index (BMI) above 25 (a measure of body weight relative to height) - People who do not have any heart or lung conditions - People whose medications have remained the same for at least 3 months - People whose weight has...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05963971 · Columbia University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 23 December 2026
🇺🇸 US

**Who might be able to join this trial:** - People between 5 and 21 years old at the time of joining the trial - People who are planning to start, or who are already receiving, a phase of cancer treatment called "maintenance" or "continuation" chemotherapy for a type of blood cancer called ALL (acute lymphoblastic leuk...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05966727 · Centre Hospitalier Universitaire de Nice Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 19 June 2026
🇫🇷 FR

**Who might be able to join this trial:** - Women who have been assessed as suitable candidates for weight-loss (bariatric) surgery, with a BMI over 40, or a BMI over 35 with at least one related health condition that surgery could help improve - Women aged between 18 and 45 years old - Women using an effective form o...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05974995 · Fondazione Policlinico Universitario Agostino Gemelli IRCCS Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2026
🇮🇹 IT

Who might be able to join this trial: - People with a Body Mass Index (BMI) of 30 or higher (considered obese range) - People aged 18 or older - People who have been diagnosed with a specific type of uterine cancer called endometrioid endometrial cancer, confirmed through a tissue sample test - People whose cancer is a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05975580 · University of California, Irvine Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 31 July 2027
🇺🇸 US

**Who might be able to join this trial:** - People aged 18 to 70 years (male or female) - People who had a sleeve gastrectomy or Roux-en-Y gastric bypass surgery at least 18 months ago - People who have regained at least 5% of their lowest weight reached after surgery - People with a body mass index (BMI) of 30 or abo...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT05977348 · Penn State University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2026
🇺🇸 US

**Who might be able to join this trial:** - Children of preschool age who are enrolled at one of the participating childcare or preschool centres **Who may not be able to join:** - Children who have severe food allergies that would prevent them from eating the foods used in the trial - Children who have a developmenta...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05982847 · North-West University, South Africa Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 30 November 2028
🇿🇦 ZA🇨🇭 CH

**Who might be able to join this trial:** - Children between the ages of 5 and under 18 years old - Children who agree to take part themselves, and whose parent or guardian also gives their permission **Who may not be able to join:** - Children whose ability to fully understand and agree to what the trial involves may...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05987631 · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 August 2024
🇳🇱 NL

**Who might be able to join this trial:** - People who are able to give informed consent to participate - People aged between 18 and 75 years old - People with a BMI of 40 or above, or a BMI of 35 or above along with a health condition related to obesity - People who are scheduled to have a primary weight-loss surgery...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05992688 · Arkansas Children's Hospital Research Institute Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 May 2026
🇺🇸 US

**Who might be able to join this trial:** - Children who are between 8 and 12 years old - Children whose weight falls in the normal range for their height and age (BMI between the 5th and 85th percentile) - Children whose weight falls in the overweight or moderately obese range for their height and age (BMI at the 85t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06009276 · University of Virginia Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇺🇸 US

**Who might be able to join this trial:** - You must be able to communicate clearly with the research team and be able to give your written consent to take part. - You must be 18 years of age or older (either male or female). **Who may not be able to join:** - You have taken antibiotic tablets or capsules in the last...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06015620 · All India Institute of Medical Sciences, Bhubaneswar Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇮🇳 IN

**Who might be able to join this trial:** - You are having a type of weight loss surgery called laparoscopic Mini Gastric Bypass (MGB) for severe obesity or health problems related to your weight **Who may not be able to join:** - You do not wish to give your consent to take part in the study - You are having a repeat...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06019182 · Eunice Kennedy Shriver National Institute of Child Health and Human De... Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2053
🇺🇸 US

Who might be able to join this trial: - Infants who appear to have symptoms of MEHMO syndrome and are at least 1 week old, or family members without symptoms who are at least 1 month old - People who show signs or symptoms that suggest MEHMO syndrome, where genetic testing has either not been done or has given unclear...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06030362 · University of California, Los Angeles Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇺🇸 US

**Who might be able to join this trial:** - People aged 18 to 50 years old - People with a body mass index (BMI) between 25 and 40 (a measure of body weight relative to height) - Both men and women are eligible - People who are not currently pregnant or breastfeeding **Who may not be able to join:** - People with Type...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06032104 · University of California, Davis Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2026
🇺🇸 US

**Who might be able to join this trial:** - People between 30 and 80 years old - People who are overweight or obese, meaning their body mass index (a measure of body weight relative to height) is 25 or above - People who are already scheduled to have a routine colonoscopy (a procedure to examine the bowel) for colon ca...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06051591 · Stanford University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 January 2027
🇺🇸 US

**Who might be able to join this trial:** **For the child:** - The child is between 6 months and under 18 months old at the time of joining the study - The child was born at 37 weeks of pregnancy or later, with no signs of malnutrition found at routine health visits - The child's household showed signs of food insecur...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06057597 · Assistance Publique - Hôpitaux de Paris Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2028
🇫🇷 FR

**Who might be able to join this trial:** - People between 18 and 65 years old - People with severe obesity (a BMI of 40 or above), or people with a BMI between 35 and 40 who also have at least one related health condition that surgery is expected to improve (such as high blood pressure, type 2 diabetes, sleep apnea, h...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06063564 · Washington University School of Medicine Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 January 2028
🇺🇸 US

**Who might be able to join this trial:** - You are between 18 and 64 years old at the start of the study - Your Body Mass Index (BMI) — a measure of body weight relative to height — is 30 or above - You currently receive your healthcare through Missouri Highlands - You are able to understand and are willing to sign an...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06067906 · Centre Hospitalier le Mans Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 2 November 2028
🇫🇷 FR

Who might be able to join this trial: - People who are covered by social security - People who have given free, informed, and written consent before joining the trial - People who are aged 18 or over but under 45 years old at the time of joining - People who have had pre-eclampsia (a serious condition during pregnancy...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06076187 · Universitaire Ziekenhuizen KU Leuven Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 25 November 2026
🇧🇪 BE

Who might be able to join this trial: - People who have signed a consent form agreeing to take part in the trial - People aged 65 or older (for Groups 1, 2, and 3) - People aged 18 to 65 (for Groups 4, 5, and 6) - People who had weight loss (bariatric) surgery between 1 and 10 years ago (for Groups 1, 2, 4, and 5) - Pe...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06105957 · University of South Carolina Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 28 February 2027
🇺🇸 US

**Who might be able to join this trial:** - People with a BMI between 25 and 55 kg/m² - People who live in a non-urban or rural area, as defined by recognised rural classification systems (confirm with trial site) - People who are able to walk at a moderate pace for at least 10 minutes without stopping, with no physica...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06111040 · Temple University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 October 2027
🇺🇸 US

Who might be able to join this trial: - The child must be 4 or 5 years old at the start of the study - The parent or main caregiver must have legal custody of the child (at least 50% of the time) - The parent or main caregiver must be mainly responsible for feeding the child outside of childcare, meaning they are prese...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06119516 · Assistance Publique - Hôpitaux de Paris Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 4 April 2027
🇫🇷 FR

**Who might be able to join this trial:** - Adults aged 18 years or older - People with a BMI over 40 kg/m², which is classified as class III (severe) obesity - People diagnosed with moderate or severe ARDS (a serious lung condition that makes breathing very difficult), as defined by a specific medical standard called...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06129110 · University of Colorado, Denver Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2028
🇺🇸 US

Who might be able to join this trial: - Generally healthy men and women between the ages of 18 and 70 - People with a Body Mass Index (BMI) between 30 and 40 (a measure of body weight relative to height) - People who do less than 1 hour of exercise per week - Women who are either pre-menopausal (still having periods) o...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06143956 · Eli Lilly and Company Phase 2 · 2 countries Recruiting
Recruiting Phase 2 Est. completion 1 September 2027
🇦🇷 AR🇺🇸 US

**Who might be able to join this trial:** - People with a Body Mass Index (BMI) of 30 or higher (BMI is a number calculated from height and weight) - People with a BMI between 27 and 30 who also have at least one health condition related to their weight (confirm with trial site for which conditions qualify) - People wh...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06147973 · Drexel University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2028
🇺🇸 US

Who might be able to join this trial: - People aged 14 to 19 years old - People who identify as a girl - People whose BMI falls at or above the 85th percentile for their age and sex (this means their weight is higher than at least 85% of others of the same age and sex — confirm with trial site if unsure how this applie...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06150898 · Jules Bordet Institute Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 20 April 2027
🇧🇪 BE

**Who might be able to join this trial:** - People who are aged between 18 and 70 years old - People who are female - People who weigh at least 35 kg - People who have been diagnosed with a type of invasive breast cancer (called invasive breast adenocarcinoma) that responds to the hormone oestrogen, confirmed by a tis...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06151015 · Moira Taylor Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2025
🇬🇧 GB

**Who might be able to join this trial:** - You are able to give written consent to take part in the study. - You are generally healthy. - You are a non-smoker. - You are male or female. - You are between 60 and 75 years old. - Your Body Mass Index (BMI — a measure of body weight relative to height) is between 25 and 4...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06173778 · The University of Texas Health Science Center, Houston Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 July 2026
🇺🇸 US

**Who might be able to join this trial:** - People who are able to give informed consent, are willing to follow all study procedures, and are available for the full duration of the trial. - People with a body mass index (BMI) of 30 or higher, OR a BMI of 27 or higher alongside at least one weight-related health condit...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06175988 · Laval University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 July 2025
🇨🇦 CA

**Who might be able to join this trial:** - People with a body mass index (BMI) between 18.5 and 35 kg/m² (a measure of body weight relative to height) - People who speak French - People who are able to travel to the Research Center of the Institut Universitaire de Cardiologie et Pneumologie de Québec for a study visit...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06192251 · Northern Ontario School of Medicine Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 6 August 2025
🇨🇦 CA

Who might be able to join this trial: - People who have been diagnosed with prediabetes (blood sugar levels higher than normal but not yet at diabetes levels) - People who have been diagnosed with type 2 diabetes - People who have been diagnosed with pre-hypertension (blood pressure slightly above normal) - People who...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06199154 · University of Maryland, Baltimore Early Phase 1 · 1 country Recruiting
Recruiting Early Phase 1 Est. completion 1 May 2026
🇺🇸 US

**Who might be able to join this trial:** - People with a BMI of 40 or higher at the time they are admitted to hospital to have their labour started - People who speak English or Spanish - People who are between 34 weeks and 42 weeks and 6 days pregnant - People aged 18 years or older - People carrying a single baby w...

Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.
NCT06207110 · University of California, San Diego Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2029
🇺🇸 US

Who might be able to join this trial: - The child and their parent or guardian must agree to take part, with the child giving their assent and the parent giving formal consent - The child must be between 7 and 12 years old and have a body weight classified as overweight or obese (at or above the 85th percentile for BMI...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06208345 · Insel Gruppe AG, University Hospital Bern Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 July 2028
🇨🇭 CH

Who might be able to join this trial: - The parents or guardians taking part must speak German - Families from any ethnic background or race are welcome - The child must live in the same home as the parent or guardian who is participating - The child must have a BMI (a measure of body weight relative to height) above t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06209996 · The University of Hong Kong Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
Hong Kong

Who might be able to join this trial: - People who identify as Chinese cancer survivors attending a one-time, in-person survivorship care clinic - People who speak Cantonese or Mandarin - People aged 18 or older - People who have been diagnosed with early-stage cancer (stage 0 to II) - People who have finished their ma...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06226194 · Institut de Recerca Biomèdica de Lleida Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 March 2027
🇪🇸 ES

**Who might be able to join this trial:** - People aged between 18 and 65 years old at the time of their weight-loss surgery - People who had one of two specific types of weight-loss surgery: a sleeve gastrectomy (stomach stapling) or a Roux-en-Y gastric bypass - People who, at the time of surgery, had a BMI of 35 or h...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06230510 · University of California, Davis Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇺🇸 US

**Who might be able to join this trial:** - The child's parent or caregiver must be willing to give their child only whole milk or only 1% milk (assigned randomly) for one year - The family must have access to a smartphone and also a tablet, laptop, or computer with internet and email at home - The parent or caregiver...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06239116 · Rhythm Pharmaceuticals, Inc. Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 November 2027
🇺🇸 US

Who might be able to join this trial: **Parts A and B (Healthy volunteer portion):** - Men and women aged 18–55 who are generally in good health at the time of screening - A body mass index (BMI) of 30 or higher (a measure of body weight relative to height) - Normal or medically unimportant results on health checks at...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06254768 · University of California, Los Angeles Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2024
🇺🇸 US

Who might be able to join this trial: - People aged 10 to 21 years old whose BMI is above the 95th percentile for their age (this means their weight is higher than 95% of people the same age, which doctors consider obesity) Who may not be able to join: - People who have previously been diagnosed with Prader-Willi Synd...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06264882 · University of Colorado, Denver Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 31 May 2028
🇺🇸 US

**Who might be able to join this trial:** - Women between the ages of 20 and 45 years old - Women who have regular menstrual cycles, meaning no more than one missed period in the past year - Women who are not currently pregnant and are not planning to become pregnant - Women who have not been breastfeeding in the last...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06275061 · Jinan University Guangzhou Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2030
🇨🇳 CN

Who might be able to join this trial: - People who have been diagnosed with obesity and are scheduled to undergo weight-loss or metabolic surgery. Who may not be able to join: - People whose obesity is being treated through non-surgical methods (such as medication, diet, or lifestyle programmes). Important: Always ve...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06278285 · Centre Hospitalier Universitaire de Nice Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 6 September 2026
🇫🇷 FR

Who might be able to join this trial: - Adults aged 18 or older - People who are able to read and understand the study information and consent form - People with a BMI over 35 who also have at least one other related health condition, or people with a BMI over 40 - People whose case for weight-loss digestive surgery ha...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06288568 · University of Vienna Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2025
🇦🇹 AT

**Who might be able to join this trial:** **As a shift worker participant:** - Works in the healthcare sector or an industrial setting - Is employed or self-employed - Is 21 years of age or older - Works at least 24 hours per week - Has been doing shift work for more than 3 years and is currently working night shifts...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06291766 · Region Skane Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2028
🇸🇪 SE

Who might be able to join this trial: - People who can understand written and spoken Swedish - People who have previously had Gastric Bypass surgery - People who have been diagnosed with gestational diabetes (diabetes during pregnancy) according to the local criteria used by the trial site - People who are planning to...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06292728 · ENDOPLY Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2025
🇨🇿 CZ

**Who might be able to join this trial:** - Your Body Mass Index (BMI) is between 30 and 40, meaning you are classified as moderately obese - You are older than 18 and younger than 60 years old - You have tried multiple diets in the past without lasting success **Who may not be able to join:** - You have a condition a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06293703 · Salvador Navarrete Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 11 December 2030
🇺🇸 US

**Who might be able to join this trial:** - People who are severely obese, with a BMI between 40 and 60 - People who understand and are willing to attend follow-up appointments over a long period of time - People who agree to take part in the study **Who may not be able to join:** - People who are unable to understand...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06299891 · Seattle Children's Hospital Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 28 February 2026
🇺🇸 US

**Who might be able to join this trial:** - People aged 6 to 28 years (male or female) - People who gained weight rapidly around the time of their brain tumor diagnosis or treatment, as assessed by an experienced hormone specialist (for example, a notable increase in weight-for-age measurements within the first 6 mont...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06321458 · Carsten Dirksen Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 1 March 2028
🇩🇰 DK🇬🇧 GB

**Who might be able to join this trial:** - People who are aged between 18 and 60 years old at the time of screening - People who have severe and complex obesity, meaning a BMI over 35 (or over 32.5 for people with South Asian, Chinese, other Asian, Middle Eastern, Black African, or African-Caribbean heritage), along w...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06335810 · Weill Medical College of Cornell University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇺🇸 US

**Who might be able to join this trial:** **Main participant (called the "Index Participant"):** - People who identify as Black or Hispanic - Men or women aged 18 or older - People with a body mass index (BMI) over 30, as measured by study staff - People who have access to a home computer or smartphone and are willing...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06339840 · Third Affiliated Hospital of Zhengzhou University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2027
🇨🇳 CN

**Who might be able to join this trial:** - Men between the ages of 22 and 40 years old. - Men with a BMI of 30 or above (classified as obesity by World Health Organization standards). - Men who are willing and able to give informed consent and attend ongoing appointments at the Reproductive Center of the Third Affili...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06341699 · Istituto Auxologico Italiano Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2026
🇮🇹 IT

**Who might be able to join this trial:** - People who have been diagnosed with morbid obesity (a severe form of obesity) **Who may not be able to join:** - People who have serious conditions affecting major body systems, a fever, or known long-term inflammatory conditions that cause a specific protein level (CRP) to...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06345560 · Chulalongkorn University Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 July 2026
🇹🇭 TH

Who might be able to join this trial: - Thai women between 18 and 45 years old who are classified as obese and have an upcoming bariatric (weight-loss) surgery appointment at Chulalongkorn Hospital - People who need a form of contraception (birth control) - People who are able to use non-hormonal birth control methods...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06345586 · Chulalongkorn University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2026
🇹🇭 TH

**Who might be able to join this trial:** - Thai women between 18 and 45 years old who are living with obesity and have a scheduled bariatric (weight-loss) surgery appointment at Chulalongkorn Hospital - Women who need a form of birth control - Women who are able to use non-hormonal birth control methods during the stu...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06363253 · Sengkang General Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇸🇬 SG

Who might be able to join this trial: - People with a Body Mass Index (BMI) over 27.5, which is a measure of body weight relative to height that falls in the obese range (obese group) - People with sarcopenia, which means having low muscle strength (weak grip strength — below 26kg for men or below 18kg for women), and/...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06364644 · Johns Hopkins University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2026
🇺🇸 US

Who might be able to join this trial: - Adults who receive care at Johns Hopkins Medicine and live in Baltimore City, or adults who receive care at Johns Hopkins Community Physicians Hagerstown or Family Healthcare of Hagerstown and live in Washington County - People living in an area ranked above the 75th percentile o...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06367296 · Universidad de La Frontera Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 28 January 2025
🇨🇱 CL

Who might be able to join this trial: - Women between 60 and 79 years old who live independently in the community (not in a nursing home or similar care facility) - People with either a normal body weight range (BMI 18.5–24.9 and body fat below 25.9%) or obesity (BMI 30–39.9 and body fat above 32%) - People who have th...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06372015 · Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bell... Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2025
🇮🇹 IT

Who might be able to join this trial: - Adults aged 18 or older who have a body mass index (BMI) over 30, which is the medical measure used to classify obesity - People who have been diagnosed with a liver or bile duct condition, confirmed using a special scanning test called FibroScan Who may not be able to join: - P...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06379113 · Xiaojun Chen Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 30 March 2026
🇨🇳 CN

Who might be able to join this trial: - People who have been diagnosed with a specific, early-stage type of uterine cancer (well-differentiated endometrial cancer, Grade 1) confirmed by a procedure called a hysteroscopy, with no growth into the uterine wall. - People with a body mass index (BMI) of 30 or higher (classi...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06380426 · Assistance Publique - Hôpitaux de Paris Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 April 2027
🇫🇷 FR

Who might be able to join this trial: - People aged 12 years or older who have already started taking a medication called semaglutide (through any arrangement, such as early access programs, standard medical care, self-funded treatment, or special reimbursement), or whose doctor has decided to start them on semaglutide...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06391320 · RenJi Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2028
🇨🇳 CN

Who might be able to join this trial: - People between 18 and 75 years old who have obesity that is not caused by another medical condition, meeting at least one of the following measurements: a BMI of 25 or above, a waist measurement of 90 cm or more for men or 80 cm or more for women, or a waist-to-hip ratio of 0.9 o...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06392854 · Mayo Clinic Early Phase 1 · 1 country Recruiting
Recruiting Early Phase 1 Est. completion 1 June 2028
🇺🇸 US

Who might be able to join this trial: - Adults between 18 and 65 years old who can understand instructions, follow study procedures, and are willing to sign a consent form. - People with a body mass index (BMI) between 29.0 and 37.0, meaning they are in the overweight to obese range. - People whose excess weight is sto...

Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.
NCT06396416 · Western University, Canada Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 30 September 2026
🇨🇦 CA

Who might be able to join this trial: - Adults who are 18 years of age or older - People with a BMI of 35 kg/m² or higher - People who have at least a 10% chance of developing kidney failure requiring dialysis or transplant within 2 years, or who are already receiving dialysis Who may not be able to join: - People who...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06409962 · Universidad de Córdoba Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 12 December 2026
🇪🇸 ES

**Who might be able to join this trial:** - Children and young people between the ages of 6 and 16 - Students attending a school that has given official approval to take part in the trial - Students for whom a signed consent form has been provided by the child or young person themselves - Students for whom a signed con...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06413264 · All India Institute of Medical Sciences, Bhubaneswar Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 May 2026
🇮🇳 IN

Who might be able to join this trial: - People aged between 18 and 65 years who are having weight-loss (bariatric) surgery performed through small incisions (laparoscopic surgery) and who weigh more than 100 kg - People whose layer of fat just under the skin measures more than 5 cm thick, as measured by an ultrasound s...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06416488 · Children's Hospital of Fudan University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2027
🇨🇳 CN

**Who might be able to join this trial:** - Children and teenagers between the ages of 7 and 18 at the start of the trial. - People who have at least one blood sugar abnormality, such as prediabetes (blood sugar levels that are higher than normal but not yet in the diabetes range). - People who have at least one abnorm...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06416969 · Mayo Clinic Early Phase 1 · 1 country Recruiting
Recruiting Early Phase 1 Est. completion 1 January 2028
🇺🇸 US

**Who might be able to join this trial:** - Adults between 18 and 65 years old who can understand instructions, follow the study procedures, and are willing to sign a consent form. - People who are overweight or obese with a body mass index (a measure of weight relative to height) between 29.0 and 40.0. - People who c...

Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.
NCT06420700 · True You Weight Loss Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 January 2028
🇺🇸 US

Who might be able to join this trial: - People who are between 18 and 65 years old. - People with a body mass index (BMI) between 28 and 55 — BMI is a number calculated from height and weight, and the trial site can confirm where someone falls on this scale. - People who are willing to follow significant long-term chan...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06425796 · University of Ulster Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 19 January 2027
🇬🇧 GB

**Who might be able to join this trial:** - Women who are pregnant and aged 18 or older - Women with a body mass index (BMI) of 18.5 or above (a standard measure of body weight relative to height) - Women who are currently pregnant without complications such as severe bleeding, diabetes during pregnancy, severe mornin...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06426693 · Yale University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 March 2027
🇺🇸 US

Who might be able to join this trial: - People aged between 18 and 60 years old - People with a body mass index (a measure of body weight relative to height) above 25 kg/m² - People who score above 2.37 on a food craving questionnaire called the Food Craving Inventory (confirm with trial site) Who may not be able to j...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06431308 · Ariel University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2026
🇮🇱 IL

**Who might be able to join this trial:** - People aged 18 or older - People whose body mass index (BMI) is 30 or higher, OR whose BMI is 27 or higher and who also have at least one weight-related health condition (such as diabetes or pre-diabetes, high blood pressure, high cholesterol, sleep apnea, fatty liver disease...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06432790 · Massachusetts General Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2028
🇺🇸 US

**Who might be able to join this trial:** - The caregiver joining the trial must be 18 years of age or older, and speak English or Spanish - The caregiver must be the primary caregiver of a child who meets the following criteria: - The child is between 4 and 17 years old at the time of screening - The child has a BMI...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06446531 · The University of Texas Health Science Center at San Antonio Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 1 July 2027
🇺🇸 US

**Who might be able to join this trial:** - People who have been diagnosed with pre-diabetes within the last 6 months, confirmed by an accepted test - People aged 18 years or older - People with a Body Mass Index (BMI) between 25 and 40 (a measure of body weight relative to height) - People whose HbA1c (a blood sugar...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06455878 · Heart Health Research Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2026
🇨🇳 CN

**Who might be able to join this trial:** - You are 18 years of age or older - Your heart is not pumping as strongly as normal (pumping 50% or less of its capacity), and you experience noticeable symptoms such as shortness of breath or tiredness during everyday activities but are still able to walk around - You are ei...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06457412 · Maimónides Biomedical Research Institute of Córdoba Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2032
🇪🇸 ES

Who might be able to join this trial: - Children who are between 6 and 12 years old with a BMI above the 99th percentile based on the Cole criteria (2004), which is a standard chart used to measure weight relative to age and height in children Who may not be able to join: - Children who are younger than 6 or older tha...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06482853 · Milton S. Hershey Medical Center Early Phase 1 · 1 country Recruiting
Recruiting Early Phase 1 Est. completion 1 March 2029
🇺🇸 US

**Who might be able to join this trial:** - Adults between 18 and 65 years of age - Men and women of any racial background - People with a body mass index (BMI) between 30 and 45 (a measure of weight relative to height that falls in the obese range) - People with elevated or high blood pressure — either pre-hypertensio...

Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.
NCT06486961 · Clinique Beau Soleil Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 November 2025
🇫🇷 FR

Who might be able to join this trial: - People who are able to walk continuously for 15 minutes without using any walking aids (such as a cane or walker) and without help from another person. - People whose Body Mass Index (BMI) is greater than 25 and less than 45. - People who understand what the study involves, inclu...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06489262 · University of Miami Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 May 2029
🇺🇸 US

Who might be able to join this trial: **For the adolescent:** - The adolescent lives with the biological parent or legal guardian who is also taking part in the trial - The adolescent identifies as Hispanic - The adolescent is between 12 and 15 years old - The adolescent has access to a smartphone - The adolescent doe...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06491537 · University of Alabama at Birmingham Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2029
🇺🇸 US

Who might be able to join this trial: - People who are 18 years of age or older - People who have recently had a healthy pregnancy with one baby (not twins or more) - People who are between 6 and 16 weeks after giving birth at the time of joining the trial - People whose body mass index (a measure of body weight relati...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06497946 · Instituto de Cardiologia do Rio Grande do Sul Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2025
🇧🇷 BR

Who might be able to join this trial: - People who have gone through menopause - People who are overweight or obese - People who have a mostly inactive or sedentary lifestyle Who may not be able to join: - People currently using hormone therapy - People currently taking prescription medication for psychiatric or menta...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06499597 · Harran University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2024
Turkey (Türkiye)

Who might be able to join this trial: - People with a body mass index (BMI) above 30 (a measure of body weight relative to height) - People who do not have any illness or condition that could affect their ability to move or perform physical tasks - People who are able to participate in and complete the tests involved i...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06502834 · Max Nieuwdorp Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 1 December 2024
🇳🇱 NL

**Who might be able to join this trial:** - You are a man, or a woman who has been through menopause - You have a larger waist size (over 102 cm / about 40 inches for men, or over 88 cm / about 35 inches for women) - You have been found to have insulin resistance, meaning your body does not respond to insulin as well a...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06504914 · University of Illinois at Chicago Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇺🇸 US

Who might be able to join this trial: - People who self-identify as Black or of African descent - People who identify as female - People who are 18 years of age or older - People whose blood pressure reading is 130/85 or higher, or who have been diagnosed with high blood pressure, and/or whose body weight falls into th...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06511297 · Thomas Scherer Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2035
🇦🇹 AT

**Who might be able to join this trial:** The trial has five separate groups, each with different requirements: - **Group 1 – Lean, young adults:** People aged 18–35 with a BMI between 18.5 and 24.9 (maintained for at least 12 months) - **Group 2 – Overweight, young adults:** People aged 18–35 with a BMI of 28 or hig...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06511310 · Joslin Diabetes Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2026
🇺🇸 US

**Who might be able to join this trial:** - People between 18 and 70 years of age - People with a BMI above 19 kg/m² and a body weight under 250 kg - People who have had bariatric (weight loss) surgery and have since regained more than 10% of the weight they originally lost, with this regain happening between 1 and 5 y...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06514820 · University Medical Center Groningen Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇳🇱 NL

Who might be able to join this trial: - People who have signs and symptoms of heart failure, as defined by European heart health guidelines - People whose heart is pumping at 40% capacity or more (a measurement called ejection fraction) - People who have scored 5 or higher on a specific heart failure assessment tool ca...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06517212 · Baylor Research Institute Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 31 August 2029
🇺🇸 US

**Who might be able to join this trial:** - People aged 18 or older, of any sex - People diagnosed within the past 15 years with breast cancer that has spread to the lymph nodes, is hormone receptor-positive (ER+ greater than 10%), and is HER2-negative, as defined by standard medical guidelines - People with cancer in...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06522529 · Instituto de Salud Carlos III Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 December 2025
🇪🇸 ES

Who might be able to join this trial: - Healthcare units such as NHS services and nursing homes that voluntarily choose to take part and provide direct patient care - Units that agree to follow evidence-based guidelines on hand hygiene, plus at least one of these topics: pain, urinary incontinence, obesity prevention,...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06538220 · Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2028
🇫🇷 FR

Who might be able to join this trial: - People who have been identified through a healthcare network or referred by a healthcare professional - People aged 18 or older - People living with obesity, meaning a BMI of 30 or above - People who understand and speak French Who may not be able to join: - People who do not wi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06547775 · Suzhou Alphamab Co., Ltd. Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 30 April 2027
🇨🇳 CN

**Who might be able to join this trial:** - People who are male and between 18 and 55 years old (inclusive) - People whose body mass index (BMI) falls between 24.0 and below 35.0 (a measure of body weight relative to height) - People whose blood sugar control levels are within a specific healthy range — specifically,...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06562660 · Henan Provincial People's Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2025
🇨🇳 CN

Who might be able to join this trial: - People between 18 and 80 years of age with a BMI of 30 or higher (classified as obese) - Male patients with obesity who are scheduled for a planned (non-emergency) surgery that does not involve the chest Who may not be able to join: - Patients who need to be awake during the bre...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06582875 · University of Colorado, Denver Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 30 June 2029
🇺🇸 US

**Who might be able to join this trial:** - Adults between 18 and 65 years of age - People who have been diagnosed with a specific inherited kidney condition called ADPKD (Autosomal Dominant Polycystic Kidney Disease), confirmed using a standard set of diagnostic criteria - People with a body mass index (a measure of b...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06590584 · Selcuk University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 28 March 2025
Turkey (Türkiye)

Who might be able to join this trial: - People with a BMI of 30 or higher (which is generally classified as obesity) - People who are able to walk - People who are 18 years of age or older - People who are willing to participate as a volunteer Who may not be able to join: - People who are currently taking medication f...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06594796 · Willeke Boonstra Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2029
🇳🇱 NL

**Who might be able to join this trial:** - People who have had non-specific lower back pain (back pain with no identified specific cause) lasting 3 months or more, and who have been referred back to a GP or primary care provider after seeing a hospital specialist - People with a body mass index (BMI) of 30 or above, O...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06595134 · University Hospital, Bonn Not Applicable · 5 countries Recruiting
Recruiting Not Applicable Est. completion 1 July 2028
🇦🇹 AT🇧🇪 BE🇨🇿 CZ🇩🇪 DE🇨🇭 CH

**Who might be able to join this trial:** - You are 45 years old or older at the time of signing the consent form - You have a Body Mass Index (BMI) of 30 or higher (which is generally considered obese) - Your doctor suspects you may have cardiovascular (heart and blood vessel) disease and has referred you for a cardia...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06596265 · Duke University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 17 June 2028
🇺🇸 US

Who might be able to join this trial: - People who are already enrolled in the Miami-Dade Fit2Lead study. - People who are between 12 and 17 years old and live in Miami-Dade County. Who may not be able to join: - People who are not already enrolled in the Miami-Dade Fit2Lead study. - People who are younger than 12 or...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06596902 · San Diego State University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2027
🇺🇸 US

Who might be able to join this trial: - Parents or guardians who are 18 years of age or older - Children who are between 6 and 11 years old - Families who live within 5 miles of one of the targeted community centers Who may not be able to join: - Parents or children who have a medical or physical condition that makes...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06597474 · Michigan State University Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 31 July 2028
🇺🇸 US

**Who might be able to join this trial:** - A parent or guardian has given consent for their child to take part, and children aged 5 have verbally agreed to join - The child is between 3 and 5 years old and attends a Head Start program, and the caregiver taking part is that child's primary adult caregiver - The caregiv...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06600100 · Raquel Vilar López Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2026
🇪🇸 ES

Who might be able to join this trial: - People with a Body Mass Index (BMI) between 25 and 39.9 (this covers the range generally described as overweight to moderately obese) - People aged between 18 and 60 years old - People who are proficient in the Spanish language - People who have access to the internet - People wh...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06602141 · AdventHealth Translational Research Institute Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2029
🇺🇸 US

Who might be able to join this trial: - Men and pre-menopausal women between 18 and 45 years old - People with a body mass index (BMI) between 30.0 and 40.0 (a measure of body weight relative to height that the trial site can calculate) - Women who are not using hormonal birth control must agree to use an approved meth...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06609200 · Nanyang Technological University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 9 April 2026
🇸🇬 SG

**Who might be able to join this trial:** - Men and women between 21 and 65 years old - People with a Body Mass Index (BMI) of 25 or higher (a standard measure of body weight relative to height) - People whose blood test results show a HOMA-IR score of 2.14 or higher — this is a measure of how well the body responds to...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06610162 · University of Colorado, Denver Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2029
🇺🇸 US

Who might be able to join this trial: **For women who still have regular periods (premenopausal):** - Women between 18 and 45 years old - Women with regular menstrual cycles, meaning no missed periods in the past year and cycle lengths between 25 and 35 days **For women who have gone through menopause (postmenopausal...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06616714 · Laterza Lucrezia Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 20 May 2026
🇮🇹 IT

**Who might be able to join this trial:** - People aged 18 to 70 years - People with a Body Mass Index (BMI) between 30 and 40 (a measure of weight relative to height that falls in the obese range) - People willing and able to understand and follow the study protocol - People who have been diagnosed with Crohn's diseas...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06617689 · St. Olavs Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇳🇴 NO

Who might be able to join this trial: - People who have been approved to receive weight-loss (bariatric) surgery at a hospital in Norway Who may not be able to join: - People who do not have sufficient skills in the language used in the trial to participate effectively - People who are not able to give informed consen...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06619041 · VA Office of Research and Development Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2027
🇺🇸 US

Who might be able to join this trial: **For Veterans:** - Adults aged 18 or older - People who have been assigned to a VA primary care provider - People who have a body weight record showing a BMI of 30 or higher in the VA medical record within the past 16 weeks before joining - People who have a second valid weight m...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06619626 · Bakirkoy Dr. Sadi Konuk Research and Training Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2024
Turkey (Türkiye)

Who might be able to join this trial: - You have been rated by doctors as having a mild to moderate physical health status (known as ASA class II or III), meaning you have some health conditions but are not critically ill - Your Body Mass Index (BMI) is between 30 and 40, meaning you are classed as obese but not severe...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06620562 · Laval University Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 June 2028
🇨🇦 CA

**Who might be able to join this trial:** - Your body mass index (BMI) is above 30 kg/m² and you have at least one health condition related to your weight (such as diabetes or high blood pressure), OR your BMI is above 35 kg/m² even without any weight-related health conditions **Who may not be able to join:** - You ha...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06621394 · University Hospital Tuebingen Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2025
🇩🇪 DE

Who might be able to join this trial: - Adults aged 18 or older - People who have been clinically diagnosed with major depression - People with at least moderate depression severity, as measured by a standard depression questionnaire (BDI-II score of 20 or higher) - People with obesity, defined as a body mass index (BM...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06622382 · Chinese University of Hong Kong Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2026
Hong Kong

**Who might be able to join this trial:** - People with a Body Mass Index (BMI) between 30 and 40 (or between 27.5 and 40 for people of Chinese or South Asian background), OR people with a BMI over 40 who are considered too high-risk for surgery or who do not wish to have surgery - People who have already tried standar...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06623669 · Wake Forest University Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 15 June 2029
🇺🇸 US

**Who might be able to join this trial:** - People aged 65 years or older - People with a body mass index (BMI) between 30 and 45, or above 45 with a doctor's approval - People whose weight has stayed relatively stable (no more than 5% change) over the past 6 months - People who have been identified as having knee or...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06626360 · HAN University of Applied Sciences Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 April 2025
🇳🇱 NL

Who might be able to join this trial: - People who are 18 years of age or older - People with a Body Mass Index (BMI) of 25 or higher, which is generally considered overweight Who may not be able to join: - People who have a physical or mental condition that prevents them from taking part in the study - People with a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06640179 · University of Kansas Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2027
🇺🇸 US

**Who might be able to join this trial:** - People who received a kidney transplant from a living or deceased donor between 3 and 5 months ago, and whose transplant doctor has given clearance to participate. - People of any gender, race, or ethnic background. - People aged 18 or older. - People with a Body Mass Index...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06645470 · University of Kansas Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2026
🇺🇸 US

**Who might be able to join this trial:** - People of any gender, race, or ethnic background are welcome to participate. - For the Randomized Study: adults aged 18 up to (but not including) 60 years old. For the Observational Study: adults aged over 60 years old. - People who have recently been prescribed a weight-los...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06668077 · Raquel Vilar López Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 November 2024
🇪🇸 ES

Who might be able to join this trial: - People with a Body Mass Index (BMI) between 25 and 39.9 (a measure of body weight relative to height) - People aged between 18 and 60 years - People who are proficient in the Spanish language - People who are right-hand dominant (right-handed as their dominant side) Who may not...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06671119 · Dr. Christopher McGowan Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2026
🇺🇸 US

**Who might be able to join this trial:** - People with a BMI of 30 or higher who have regained at least 25% of the weight they originally lost after sleeve gastrectomy surgery (where that surgery was initially considered successful) - People who had their sleeve gastrectomy surgery at least three years before joining...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06672549 · Eli Lilly and Company Phase 3 · 8 countries Recruiting
Recruiting Phase 3 Est. completion 1 February 2027
🇧🇷 BR🇮🇱 IL🇮🇹 IT🇯🇵 JP🇲🇽 MX🇵🇱 PL🇬🇧 GB🇺🇸 US

Who might be able to join this trial: - People who have previously tried a structured weight loss program (including diet and exercise guidance for at least 3 months) without losing enough weight. - People aged 12 to under 18 whose BMI is at or above the 95th percentile for their age and sex, which is considered obesit...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06672939 · Eli Lilly and Company Phase 3 · 6 countries Recruiting
Recruiting Phase 3 Est. completion 1 December 2027
🇮🇱 IL🇮🇹 IT🇯🇵 JP🇵🇱 PL🇬🇧 GB🇺🇸 US

**Who might be able to join this trial:** - You have tried at least one structured weight loss program (including diet and exercise counseling for at least 3 months) in the past, but did not lose enough weight. - Your BMI is at or above the 95th percentile for your age and sex (meaning you are in the category consider...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06673550 · Mater Olbia Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2024
🇮🇹 IT

Who might be able to join this trial: - You are over 18 years old - You are living with obesity (any grade) or you are overweight and have at least one health condition related to your weight (such as diabetes or high blood pressure) (confirm with trial site) Who may not be able to join: - You have previously had weig...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06684834 · University of Bath Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2025
🇬🇧 GB

**Who might be able to join this trial:** - Your waist measurement is 94 cm (37 inches) or more if you are male, or 80 cm (31.5 inches) or more if you are female, OR your BMI is above 25 kg/m² - Your body fat levels are above a certain amount, measured as a "fat mass index" — above 6 kg/m² for males and above 9 kg/m² f...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06689241 · Alexandria University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇪🇬 EG

Who might be able to join this trial: - People between the ages of 20 and 60 years old, of any sex. - People with a general health status rated as ASA Class I to III, meaning those in good health or with mild to moderate health conditions (confirm with trial site). - People with a Body Mass Index (BMI) between 35 and 5...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06690788 · University of Utah Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2028
🇺🇸 US

**Who might be able to join this trial:** - One partner (the "target partner") must have a body mass index (BMI) of 25 or higher (or 23 or higher if they are Asian American) — this is a measure of body weight relative to height - The target partner must not have been diagnosed with type 1 or type 2 diabetes - The targ...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06691100 · George Washington University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2027
🇺🇸 US

Who might be able to join this trial: - People who are biologically female - People with a BMI in the range of 19 to 24.99, or in the range of 30 to 40 - People who exercise at least 4 times per week for a total of at least 240 minutes per week, doing structured training such as running, cycling, triathlon, powerliftin...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06703788 · Chang Gung Memorial Hospital Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 June 2025
🇹🇼 TW

**Who might be able to join this trial:** - You are between 20 and 75 years old and are covered by health insurance - You are a man with a waist circumference of 90 cm (about 35.5 inches) or more, or a woman with a waist circumference of 80 cm (about 31.5 inches) or more - Your fasting blood sugar is 100 mg/dL or highe...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06714058 · IRCCS Azienda Ospedaliero-Universitaria di Bologna Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 April 2025
🇮🇹 IT

**Who might be able to join this trial:** - You are over 18 years old - Your Body Mass Index (BMI, a measure of body weight relative to height) is above 30, which is generally considered obese - You have not yet had a heart attack, stroke, or other cardiovascular (heart and blood vessel) event — meaning you are being s...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06714929 · Virginia Commonwealth University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 May 2027
🇺🇸 US

Who might be able to join this trial: - Students from Kindergarten through 5th grade (and Pre-Kindergarten where applicable) who eat lunch in the school cafeteria on the days when observations are taking place are eligible for the lunchroom observation part of the study. - Students who are enrolled in the study while i...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06715358 · Foundation for Science, Health and Education, Spain Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2030
🇪🇸 ES

Who might be able to join this trial: - Schools located in the Madrid Region or Catalonia, Spain - Public or charter (partially state-funded) schools - Schools that include grades 1 through 6 and have at least one 1st grade classroom - Schools that have an on-site canteen (school cafeteria) - Children who are currently...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06719102 · University of Texas at Austin Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2028
🇺🇸 US

**Who might be able to join this trial:** - The baby must be a single birth (not a twin or multiple) and be between 3 and 9 weeks old. - The baby must have been born at full term (at or after 37 weeks of pregnancy). - The mother must be at least 18 years old. - Any other caregiver involved must also be at least 18 year...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06720246 · I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2027
🇮🇹 IT

**Who might be able to join this trial:** - People of any ethnicity between the ages of 20 and 60 years old - People with a Body Mass Index (BMI) of 30 or higher (a measure of body weight relative to height) - People with no history of neurological or psychiatric conditions, as confirmed through medical history and scr...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06720571 · University of Bordeaux Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 March 2026
🇫🇷 FR

Who might be able to join this trial: **For people with Prader-Willi syndrome (PWS):** - People who are 18 years of age or older - People who have a confirmed diagnosis of Prader-Willi syndrome with an identified genetic type - People whose cognitive testing (a standardised thinking and reasoning assessment called WAI...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06721507 · Marlene Starr Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 31 December 2026
🇺🇸 US

**Who might be able to join this trial:** - Adults who are already enrolled in the multidisciplinary weight loss surgery program at UK HealthCare Weight Loss Surgery Clinic and are scheduled to have sleeve gastrectomy or gastric bypass surgery (laparoscopic or robotic) - People with a BMI of 40 or higher who also have...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06722391 · University of Texas, El Paso Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2029
🇺🇸 US

Who might be able to join this trial: - People who are overweight or obese, meaning their Body Mass Index (BMI) is 25 or higher - People who live a mostly sedentary (inactive) lifestyle, based on a standard activity level measurement (confirm with trial site) - People who currently do less than 150 minutes per week of...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06724406 · University of North Carolina, Chapel Hill Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2028
🇺🇸 US

Who might be able to join this trial: - People who identify as Black or African American (this applies to the main participant) - Main participants with a BMI of 30 or higher; family/partner participants with a BMI of 27.5 or higher - People who have a family member or partner who is also willing to join the study, and...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06729203 · Cairo University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2025
🇪🇬 EG

**Who might be able to join this trial:** - Women who carry excess weight around their midsection (central obesity) - Women between 25 and 40 years of age - Women with a Body Mass Index (BMI) between 30 and 35 (a measure of body weight relative to height) - Women with a waist measurement greater than 88 cm, which indi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06736028 · University of Alabama at Birmingham Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇺🇸 US

Who might be able to join this trial: - People with a BMI between 30 and 45 kg/m² - Both men and women are eligible - People between 18 and 65 years old - People who exercise less than 2 hours per week of moderate, structured, intentional physical activity (ranging from not exercising at all to being only lightly activ...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06739473 · Turku University Hospital Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 December 2024
🇫🇮 FI

Who might be able to join this trial: - You are between 20 and 60 years old - Your body weight falls into one of two specific ranges: either a healthy/normal weight (BMI 18.5–25) or obese (BMI above 30) - Women who could become pregnant must be using hormonal birth control (such as the pill or a hormonal coil) Who may...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06745063 · VA Office of Research and Development Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 31 December 2028
🇺🇸 US

**Who might be able to join this trial:** - People with a Body Mass Index (BMI) between 30 and 45 — this is a measure of body weight relative to height. - People who are between 30 and 60 years old at the time of joining the trial. - People whose arteries show signs of stiffening, measured during a screening test using...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06753669 · University of Massachusetts, Worcester Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 28 February 2029
🇺🇸 US

**Who might be able to join this trial:** - The mother (or primary caregiver) must be 18 years of age or older - The mother must speak and read/write Bengali or Hindi/Urdu - The mother must have been born in a South Asian country - The mother must be the main caregiver for the child - The child must be between 12 and...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06755827 · Texas Tech University Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 31 December 2026
🇺🇸 US

Who might be able to join this trial: - People who are proficient in English - Young people between the ages of 11 and 14 - Young people whose BMI is at or above the 85th percentile for their age and sex (a measure used to assess body weight relative to other children of the same age and sex) - People who have access t...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06759324 · Associação Centro de Apoio Tecnológico Agro Alimentar Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 28 February 2025
🇵🇹 PT

**Who might be able to join this trial:** - People aged between 18 and 60 years old - People with a Body Mass Index (BMI) between 25 and 34.9 (a measure of body weight relative to height — confirm the exact calculation with the trial site) - People of any biological sex - People who are able to follow the study schedul...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06768437 · University of Leicester Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2027
🇬🇧 GB

Who might be able to join this trial: - People who are willing and able to give their informed consent to take part in the study - People aged 18 years or older - People who have been diagnosed with a specific type of heart failure called HFpEF by an experienced heart specialist, or who have signs and symptoms of heart...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06770049 · Mayo Clinic Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2028
🇺🇸 US

Who might be able to join this trial: - Men or women between 18 and 65 years old who have obesity, meaning a BMI (body mass index) above 30 kg/m² Who may not be able to join: - People whose weight has changed by more than 3% in the past 3 months - People who have previously had weight-loss surgery or a weight-loss pro...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06777498 · Cornell University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2025
🇺🇸 US

**Who might be able to join this trial:** - People aged between 21 and 50 years old - People with a BMI between 25 and 30 - People who are able to have their height, weight, waist, hip circumference, and body composition measured during the study - People who are able to provide saliva samples - People who are able to...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06778850 · MindRank AI Ltd Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 15 July 2025
🇨🇳 CN

Who might be able to join this trial: - People aged 18 to 55 years old at the time of signing the consent form, of any gender. - People with a Body Mass Index (BMI) between 27 and 45 kg/m² (a measure of body weight relative to height). - Male participants with a waist measurement of 90 cm or more, or female participant...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06780813 · National and Kapodistrian University of Athens Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2026
🇬🇷 GR

Who might be able to join this trial: - People with a BMI over 30 (classified as obese) who have been diagnosed with a gynaecological cancer - People whose blood test results have been optimised before surgery, including healthy levels of red blood cells, white blood cells, and platelets - People who received chemother...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06781762 · University of Toronto Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2026
🇨🇦 CA

**Who might be able to join this trial:** **Case group (people with breast cancer):** - People who are biologically female - People who have gone through natural menopause (periods stopped on their own, without surgical removal of the ovaries) for at least 1 year - People who have used hormone replacement therapy (HRT...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06785064 · University of Alabama at Birmingham Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 November 2028
🇺🇸 US

**Who might be able to join this trial:** - You are over 18 years old - Your body mass index (BMI) is over 30 (a measure of body weight relative to height — confirm with trial site if unsure of your BMI) - You have regular access to the internet, as sessions are held over Zoom video calls - If required during the scree...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06789965 · Hospital Clinic of Barcelona Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2026
🇪🇸 ES

Who might be able to join this trial: - Your body mass index (BMI) is between 40 and 50 (a measure of weight relative to height that indicates severe obesity) - You have been assessed as suitable for a type of weight-loss surgery that combines restriction and malabsorption (confirm with trial site) Who may not be able...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06790329 · Chinese University of Hong Kong Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
Hong Kong

**Who might be able to join this trial:** - Your Body Mass Index (BMI) is between 30 and 40, or 27.5 and 40 if you are Chinese or South Asian (BMI is a measure based on your height and weight) - Your BMI is above 40 and you are either considered too high-risk for weight-loss surgery, or you do not wish to have surgery...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06799897 · ETH Zurich Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 18 January 2026
🇨🇭 CH

**Who might be able to join this trial:** - People who have signed a consent form agreeing to take part in the study - People aged between 18 and 60 years old - People with a Body Mass Index (a measure of body weight relative to height) between 30 and 50 - People who can read and speak German well enough to understand...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06800911 · Istituto Auxologico Italiano Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 May 2026
🇮🇹 IT

Who might be able to join this trial: - People who are between 18 and 65 years old - People who are Italian nationals - People with a Body Mass Index (BMI) of 35 or higher (this is a measure of body weight relative to height — confirm with the trial site if unsure how to calculate this) Who may not be able to join: -...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06802081 · The Cleveland Clinic Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 31 December 2026
🇺🇸 US

**Who might be able to join this trial:** - People who are in a normal heart rhythm (called sinus rhythm) at the time of joining the trial - People aged 18 to 80 years old - People with a Body Mass Index (BMI) between 27 and 60 - People who have been diagnosed with atrial fibrillation (an irregular heartbeat), confirm...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06809166 · The Royal's Institute of Mental Health Research Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 January 2026
🇨🇦 CA

**Who might be able to join this trial:** - People who are able to give written consent before any study procedures begin. - People who have been referred to the LEAF clinic by their doctor, or who have referred themselves to the LEAF clinic for weight loss, and who the LEAF clinic team has determined are appropriate...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06811324 · The University of Texas Health Science Center at San Antonio Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 April 2027
🇺🇸 US

Who might be able to join this trial: - Men and postmenopausal women who are 50 years of age or older - People with a Body Mass Index (BMI) of 30 or above (a measure of body weight relative to height) - People whose blood sugar control (measured by a test called HbA1c) is below 6.5% and who are not currently taking any...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06816147 · Luxembourg Institute of Health Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2026
🇱🇺 LU

Who might be able to join this trial: - You are 60 years old or older - You are male or female and live independently in the community (not in a care facility) - You currently live in Luxembourg - Your body weight falls in the normal or overweight range (your BMI is between 18.5 and 30 kg/m²) (confirm with trial site i...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06824974 · University of California, San Diego Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
🇺🇸 US

**Who might be able to join this trial:** - People with a Body Mass Index (BMI) between 27 and 45, meaning they are overweight or obese - People who have been diagnosed with a liver condition, specifically fatty liver disease (MASLD/NAFLD), liver inflammation related to metabolic issues (MASH), cirrhosis, or an early-t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06826963 · Universita di Verona Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2025
🇮🇹 IT

**Who might be able to join this trial:** - People aged between 65 and 85 years old - People who have been diagnosed with stable heart failure where the heart is either pumping normally (preserved function) or pumping with reduced strength (confirm with trial site for specific measurements) - People whose heart failur...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06829381 · Tel-Aviv Sourasky Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 January 2029
🇮🇱 IL

Who might be able to join this trial: - You are 18 years old or older and are scheduled to have a type of weight loss surgery called One Anastomosis Gastric Bypass (OAGB) (confirm with trial site) Who may not be able to join: - You are under 18 years old, are pregnant, or are unable to make your own decisions about ta...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06831045 · University of Miami Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2028
🇺🇸 US

Who might be able to join this trial: - People with a body mass index (BMI) of 30 or higher (this is a standard weight-to-height measurement) - People scheduled to have their first total hip replacement surgery on one hip using a specific surgical approach called the Direct Anterior Approach (DAA) - People undergoing a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06835686 · Tulane University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 March 2028
🇺🇸 US

Who might be able to join this trial: - You are between 18 and 75 years old - You have obesity, meaning your BMI is between 30 and 50 if you are non-Asian, or between 27.5 and 50 if you identify as Asian - You weigh less than 400 pounds - You currently receive care at a participating community health clinic, or are wil...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06842186 · Wave Life Sciences USA, Inc. Phase 2 · 4 countries Recruiting
Recruiting Phase 2 Est. completion 1 December 2027
Moldova🇷🇴 RO🇬🇧 GB🇺🇸 US

Who might be able to join this trial: **Part A (Healthy volunteers):** - Adults aged 18 to 60 years, male or female - Body mass index (a measure of weight relative to height) between 28 and 35, which has been stable (within about 5%) for the past 3 to 6 months — or up to 40 for certain expanded groups - Generally heal...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06844786 · Hamilton Health Sciences Corporation Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 August 2027
🇨🇦 CA

Who might be able to join this trial: - Families who have moved to Canada within the last 10 years and have at least one child between the ages of 5 and 11 (up to but not including age 12) living in Hamilton, Ontario. - At least one parent or guardian in the family must have been born outside of Canada and must have be...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06848491 · UNC Lineberger Comprehensive Cancer Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 April 2028
🇺🇸 US

**Who might be able to join this trial:** - People who are between 18 and 39 years old at the time of signing up for the trial - People who were first diagnosed with an invasive cancer between the ages of 15 and 39 (based on self-report) - People who were diagnosed no more than 10 years ago and have no signs of the ca...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06849206 · Pennington Biomedical Research Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 24 February 2045
🇺🇸 US

Who might be able to join this trial: - Children, teenagers, and young adults from birth up to age 24, along with their close family members (such as parents and siblings) - Adults aged 25 or older who are either pregnant or trying to become pregnant - People who live in Louisiana (based on self-report) - People who ar...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06855251 · Istituto Auxologico Italiano Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 March 2026
🇮🇹 IT

Who might be able to join this trial: - People who are right-handed and have been diagnosed with obesity - People who are currently receiving rehabilitation treatment at the Istituto Auxologico Who may not be able to join: - People who have been diagnosed with neurological conditions, neurodevelopmental conditions (su...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06858683 · Hospital Universitari Vall d'Hebron Research Institute Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇪🇸 ES

**Who might be able to join this trial:** - You are a woman aged between 18 and 64 years old - Your Body Mass Index (BMI) is between 40 and 50 (a measure of weight relative to height) - You are scheduled to have weight-loss (bariatric) surgery 10 to 12 weeks after the nutrition programme begins - You currently spread y...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06858761 · Hospices Civils de Lyon Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2028
🇫🇷 FR

**Who might be able to join this trial:** - People aged between 18 and 70 years old, of any gender - People who are having bariatric or metabolic (weight-loss) surgery for the first time, with a body weight that falls into one of these categories: a BMI of 40 or above; OR a BMI of 35 or above with at least one related...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06861868 · Johns Hopkins University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 March 2029
🇺🇸 US

**Who might be able to join this trial:** - People who are already part of the RESONANCE research cohort (an existing group of study participants) and who will be between 7 and 12 years old during the study period - People in that group who have no food allergies **Who may not be able to join:** - People who were expo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06862908 · Innovent Biologics (Suzhou) Co. Ltd. Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 24 September 2026
🇨🇳 CN

**Who might be able to join this trial:** - People aged 18 or older at the time of signing the consent form - People with a BMI of 28 or higher - People whose heart failure symptoms fall into a moderate category (NYHA Class II or III) (confirm with trial site) - People who have not been hospitalised due to heart failu...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06867354 · Assistance Publique - Hôpitaux de Paris Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2027
🇫🇷 FR

**Who might be able to join this trial:** - People who have been on a breathing machine (mechanical ventilator) for at least 48 hours - People who are on a ventilator setting that allows them to take some breaths on their own, with the machine providing support, and where the breath size and pressure settings fall wit...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06868862 · Laboratoire des Adaptations Métaboliques à l'Exercice en conditions Ph... Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2025
🇧🇷 BR

Who might be able to join this trial: - Women who are overweight or obese, with a BMI (body mass index) between 25 and 35 kg/m² Who may not be able to join: - Women who are currently using contraceptives (birth control) - Women who have gone through menopause - Women who have an irregular menstrual cycle - Women who h...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06869941 · Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 January 2027
🇪🇸 ES

**Who might be able to join this trial:** - Adults (men and women) who are older than 20 years of age - People who are already scheduled for a surgical procedure to remove fat tissue from the body - People who have given signed written consent to take part in the study **Who may not be able to join:** - People who hav...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06874309 · Masaryk University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇨🇿 CZ

Who might be able to join this trial: - People who have severe or morbid obesity, meaning a BMI over 35 or 40 kg/m², and who meet current medical guidelines for bariatric (weight-loss) surgery. - People who show signs of reduced control over their eating habits, as measured by a specific questionnaire called the Eating...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06891534 · Mayo Clinic Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2029
🇺🇸 US

Who might be able to join this trial: - People with a body mass index (BMI) in either the 20–25 range (considered a healthy weight) or the 30–37 range (considered obese) - People in the obese BMI range who also have a waist-to-hip ratio of 0.95 or higher (males) or 0.90 or higher (females), which is a measurement compa...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06892483 · Mayo Clinic Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 10 October 2027
🇺🇸 US

**Who might be able to join this trial:** *(This trial defines eligibility based on activity level — please confirm the specific requirements for each group with the trial site.)* - People who fit into either an "inactive" group or an "active" group based on how often they currently exercise (confirm with trial site...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06893016 · Guangdong Raynovent Biotech Co., Ltd Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 15 June 2026
🇨🇳 CN

**Who might be able to join this trial:** - Adults aged 18 or older. - People with a body mass index (BMI) of 28 or above, OR a BMI between 24 and 28 who also have at least one weight-related health condition, such as: high blood pressure or use of blood pressure medication; abnormal cholesterol or triglyceride levels...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06897241 · Chalmers University of Technology Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2026
🇸🇪 SE

**Who might be able to join this trial:** - Men and post-menopausal women between the ages of 30 and 75 - People with a body mass index (a measure of body weight relative to height) between 27 and 40 - People with a waist measurement greater than 102 cm (for men) or 88 cm (for women) - People whose weight has stayed ro...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06897982 · Cedars-Sinai Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 28 February 2027
🇺🇸 US

**Who might be able to join this trial:** - People who are 18 years of age or older - People with a BMI of 25 or higher (or 23 or higher if the person is of Asian background) - People whose blood sugar test results fall within the prediabetes range, such as a fasting blood sugar level between 110–125 mg/dL or an A1C le...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06911073 · ResBiotic Nutrition, Inc. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2025
🇺🇸 US

**Who might be able to join this trial:** - People who are willing and able to give voluntary, signed, and dated consent to take part. - People who are in good general health based on their medical history. - People aged between 18 and 65 years (inclusive). - People with a Body Mass Index (BMI) between 25.0 and 40.0 (i...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06912100 · University of Connecticut Early Phase 1 · 1 country Recruiting
Recruiting Early Phase 1 Est. completion 31 December 2026
🇺🇸 US

Who might be able to join this trial: - People aged between 18 and 60 years old - People with a body mass index (BMI) between 28 and 40 (a measure of body weight relative to height — confirm with trial site if unsure of your BMI) - Women with a waist circumference of 88 cm (35 inches) or more, or men with a waist circu...

Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.
NCT06916208 · University of Avignon Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2027
🇫🇷 FR

**Who might be able to join this trial:** - People aged between 11 and 18 years old - People who are covered by a health insurance scheme - People whose Body Mass Index (a measure of body weight relative to height) falls within the range classified as "stage 2 obesity" based on specific growth charts, and who have not...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06918821 · University of Houston Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 28 February 2029
🇺🇸 US

**Who might be able to join this trial:** - Parents or legal guardians who are the primary caregiver of a toddler, are over 18 years old, have regular and frequent access to the internet, and are fluent in English. - Toddlers who are between 18 and 36 months of age and are able to walk. **Who may not be able to join:...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06920862 · National Yang Ming Chiao Tung University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 July 2028
🇹🇼 TW

**Who might be able to join this trial:** - Adolescents between the ages of 12 and 18 years old. - Those whose Body Mass Index (BMI) falls at or above the 85th percentile based on Health Promotion Administration standards (confirm with trial site if unsure how this applies). - Those who are willing to take part in a di...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06923644 · Maastricht University Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2027
🇳🇱 NL

**Who might be able to join this trial:** - Adults (men and women) with a BMI of 25 or above but below 40 (meaning they are overweight or moderately obese) - People whose health profile matches one of the specific metabolic types being studied in this trial (determined by a classification process) - People whose weight...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06924177 · University of Texas Southwestern Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 May 2027
🇺🇸 US

Who might be able to join this trial: - People between 18 and 65 years old - People who have had a spinal cord injury for more than one year - People who are not able to walk around independently - People who mainly use a wheelchair to get around - People who live in the community (rather than in a care facility) - Peo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06929000 · Maternal and Child Health Hospital of Hubei Province Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 22 February 2026
🇨🇳 CN

Who might be able to join this trial: - People who have chosen to have a surgical abortion with general anaesthesia (so they are asleep and feel no pain during the procedure) - People with a Body Mass Index (BMI) greater than 24 (a measure of body weight relative to height) - People who are considered generally healthy...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06934408 · Fujian Shengdi Pharmaceutical Co., Ltd. Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 1 April 2027
🇨🇳 CN

Who might be able to join this trial: - People who are willing to voluntarily sign a consent form, understand what the study involves, and agree to follow the study procedures throughout. - Men or women between 18 and 55 years old (inclusive). - People who are generally in good health, as assessed by the study doctor b...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06934681 · Instituto de Investigacion Sanitaria La Fe Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2028
🇪🇸 ES

Who might be able to join this trial: - People who are between 18 and 65 years old - People with a body mass index (BMI) of 35 or higher who also have at least one other health condition related to their weight, or people with a BMI of 40 or higher regardless of any other health conditions Who may not be able to join:...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06943170 · Riphah International University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 July 2025
🇵🇰 PK

**Who might be able to join this trial:** - Children between 8 and 16 years old - Both boys and girls are eligible - Children whose BMI-for-age falls at or above the 85th percentile (considered overweight) or at or above the 95th percentile (considered obese) - Children who are generally in stable health, without serio...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06945016 · Wageningen University and Research Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 28 January 2040
🇳🇱 NL

**Who might be able to join this trial:** - People who were female at birth - People aged between 18 and 55 years old - People living with obesity, meaning a Body Mass Index (BMI) of 30 or higher - People who have been approved for obesity treatment at one of the participating hospitals - People who are having a speci...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06961591 · University of Kansas Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2028
🇺🇸 US

**Who might be able to join this trial:** - People who have been diagnosed with mild-to-moderate intellectual disability - People between 18 and 35 years of age - People with a BMI over 24.9 and a body weight under 350 pounds - People who can follow instructions, express their preferences (such as food choices), and co...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06963736 · Arizona State University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 July 2026
🇺🇸 US

**Who might be able to join this trial:** - You are 26 years of age or older - Your body weight falls into a higher BMI category (BMI of 27 or above for most people, or 25 or above if you are of Asian heritage, either fully or partially) - You are not getting enough physical activity — specifically, less than 150 minut...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06964880 · China Medical University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2025
🇹🇼 TW

**Who might be able to join this trial:** - People who are undergraduate medical university students in years 1 to 4 at a university in central Taiwan - People whose Body Mass Index (BMI) falls between 23 and 27, or whose body fat percentage is between 25% and 35% - People aged between 18 and 25 years old - People who...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06966258 · University of Alabama at Birmingham Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 January 2029
🇺🇸 US

Who might be able to join this trial: - People who identify as Black women (based on self-report) - Adults between the ages of 30 and 79 years old - People who have been diagnosed with Stage 2 or higher Cardiovascular-Kidney-Metabolic Syndrome (a condition involving related problems with the heart, kidneys, and metabol...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06968442 · Franciscus Gasthuis Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇳🇱 NL

Who might be able to join this trial: **Cohort 1 – Obesity group:** - Adults aged 18 to 65 years old - A body mass index (BMI) of 30 or higher, which is generally considered the obesity range - Must be a patient at Franciscus Hospital **Cohort 2 – Comparison group:** - Adults aged 18 to 65 years old - A BMI below 25,...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06970457 · Oklahoma State University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇺🇸 US

Who might be able to join this trial: - People who are biologically male - People with a BMI either in the range of 18.5–24.9 kg/m² (considered a "normal" weight range) or 30 kg/m² and above (considered obese) - People with a body fat percentage either below 20% or 25% and above - People who are able and willing to fol...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06971159 · Laboratorio de Vibraçoes Mecanicas e Praticas Integrativas Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2029
🇧🇷 BR

**Who might be able to join this trial:** - People of any sex - People who have obesity - People who are over 18 years old **Who may not be able to join:** - People with a Body Mass Index (BMI) below 30 kg/m² (a measure of body weight relative to height) - People with high blood pressure that is not being treated or c...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06976112 · Pennington Biomedical Research Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇺🇸 US

**Who might be able to join this trial:** - People who are female - People between 40 and 55 years of age - People with a BMI (a number based on height and weight) between 28 and 45 kg/m² - People who have irregular menstrual cycles but have not gone 12 or more consecutive months without a period - People who are expe...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06982131 · Hoffmann-La Roche Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 4 December 2026
🇳🇱 NL

**Who might be able to join this trial:** - People who are generally healthy, with no significant findings on physical examination, blood tests, urine tests, or heart tracing (ECG) at the time of screening - People who show no signs of memory problems or dementia, as assessed by the trial doctor - People who are not u...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06986993 · University of Oklahoma Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 30 May 2028
🇺🇸 US

Who might be able to join this trial: - People who are between 18 and 65 years old - People who smoke more than 2 cigarettes per day on a daily basis - People who have a Body Mass Index (BMI) of 30 or higher, which is the medical threshold for obesity - People who do not currently want to quit smoking Who may not be a...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06987279 · Wecare Probiotics Co., Ltd. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 10 September 2025
🇨🇳 CN

**Who might be able to join this trial:** - Women between 18 and 40 years old with a body mass index (BMI) of 25 or higher (a measure of body weight relative to height) - People who are willing to attend follow-up appointments during the study period - People who are willing to provide two samples of blood, urine, and...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06987903 · Fundacin Biomedica Galicia Sur Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2028
🇪🇸 ES

**Who might be able to join this trial:** - You are scheduled to have weight-loss (bariatric) surgery at the General and Digestive Surgery Department of Álvaro Cunqueiro Hospital in Vigo. - You are between 18 and 69 years old. - You are willing and able to sign a consent form agreeing to take part in the study. **Who...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06988462 · Cambridge Health Alliance Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 25 August 2026
🇺🇸 US

Who might be able to join this trial: - Adults between 18 and 60 years old - People who currently live in Massachusetts - People who have at least one of the following: low "good" (HDL) cholesterol, high "bad" (LDL) cholesterol, high triglycerides (a type of fat in the blood), obesity, a blood sugar reading of 5.7% or...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06991296 · University of North Carolina, Chapel Hill Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇺🇸 US

**Who might be able to join this trial:** - Adults between the ages of 45 and 60 years - People with a Body Mass Index (BMI) between 30 and 40 (a measure of body weight relative to height that a doctor can calculate) - People of any racial or ethnic background **Who may not be able to join:** - People younger than 45...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06994923 · The Miriam Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2027
🇺🇸 US

Who might be able to join this trial: - People with a Body Mass Index (BMI) of 25 or higher (BMI is a measure based on height and weight) - People who are enrolled as a student at the college or university where the study is being run - People who speak English Who may not be able to join: - People who have been diagn...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07013409 · Wecare Probiotics Co., Ltd. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2025
🇨🇳 CN

Who might be able to join this trial: - You are a woman between 18 and 40 years old with a body mass index (BMI) of 25 or higher (meaning you are classed as overweight or obese based on standard BMI charts). - You are willing to attend follow-up appointments during the study period. - You are willing to provide two sam...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07020741 · University of Illinois at Urbana-Champaign Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 August 2026
🇺🇸 US

Who might be able to join this trial: - People between the ages of 19 and 59 years old - People with a BMI (a measure of body weight relative to height) of 30 or above, and a waist measurement of 102 cm or more (for men) or 88 cm or more (for women) - People who score less than 14 units on a standard leisure-time activ...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07027033 · Nantes University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2028
🇫🇷 FR

**Who might be able to join this trial:** - People who have given their informed consent to participate. - Women aged between 18 and 60 years old (inclusive). - People with obesity who meet the French health authority (HAS) criteria for bariatric (weight-loss) surgery — meaning a BMI of 35 or above with at least one re...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07033221 · Istanbul Aydın University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2026
Turkey (Türkiye)

Who might be able to join this trial: - People whose native language is Turkish - People between the ages of 18 and 60 - People with a body mass index (BMI) of 40 or above, meaning they have been assessed as suitable for weight-loss (bariatric) surgery - People who have not previously been diagnosed with a balance or i...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07035093 · Eli Lilly and Company Phase 3 · 4 countries Recruiting
Recruiting Phase 3 Est. completion 1 September 2027
🇦🇷 AR🇨🇦 CA🇵🇱 PL🇺🇸 US

Who might be able to join this trial: - People who have a history of low back pain that is mainly centred in the back (rather than coming from another part of the body) - People whose pain stays in the lower back or spreads only partway down the upper legs - People with a body mass index (BMI) of 27 or higher at the ti...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07039279 · Chinese University of Hong Kong Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 October 2030
Hong Kong

Who might be able to join this trial: - You have been diagnosed with type 2 diabetes - You have a body mass index (BMI) of 27.5 or higher, and/or a waist measurement of 80cm or more (women) or 90cm or more (men) - You are between 18 and 50 years old - You are comfortable using a smartphone and web-based programs - You...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07043166 · Shanghai Changzheng Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 May 2035
🇨🇳 CN

**Who might be able to join this trial:** - People who are among the 4,094 residents of Shanghai communities already enrolled in the STONE cohort study - People who completed the original baseline questionnaire, physical check-up, and related medical tests between 2016 and 2017, with full and complete records from that...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07049861 · Washington University School of Medicine Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 December 2028
🇺🇸 US

**Who might be able to join this trial:** **Healthcare Providers (called "Provider Trainees"):** - Primary care providers working at one of the participating clinics, including Medical Doctors (MD), Doctors of Osteopathic Medicine (DO), Physician Assistants (PA), or Nurse Practitioners (NP) who have already finished t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07051109 · Seoul National University Bundang Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 11 August 2025
🇰🇷 KR

Who might be able to join this trial: - Adult women between the ages of 19 and 65 - People who have been assessed by an anaesthetist as being in generally good to moderate health before surgery (confirm with trial site for exact health rating) - People who are scheduled to have a laparoscopic sleeve gastrectomy (a type...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07053657 · Anhui Medical University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 December 2025
🇨🇳 CN

Who might be able to join this trial: - Students whose parent or guardian has signed a consent form agreeing to their participation - Students with a blood vitamin D level (measured as 25(OH)D) between 12 and 20 ng/mL — this is considered low but not severely deficient - Students who are classified as overweight or obe...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07057245 · Maastricht University Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇳🇱 NL

**Who might be able to join this trial:** - Men and women between 60 and 75 years old - People with a body mass index (BMI) between 25 and 35, which falls in the overweight to moderately obese range - People whose fasting blood sugar level is below 7.0 mmol/L (measured after not eating) - People whose fasting total cho...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07057453 · Institute of Health Information and Statistics of the Czech Republic Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2026
🇨🇿 CZ

Who might be able to join this trial: - Children who are between 6 and 11 years old - Children whose BMI (a measure of body weight relative to height) falls between the 90th and 97th percentile for their age group - A parent or guardian has signed a consent form agreeing to participate, including data privacy terms Wh...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07058155 · The Cleveland Clinic Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 February 2029
🇺🇸 US

**Who might be able to join this trial:** - People who are suitable candidates for general anaesthesia - People aged between 18 and 70 years old at the time of giving consent - People with a body mass index (BMI) between 35 and 70 at their first study visit - People who meet the medical guidelines (ASMBS/IFSO 2022) fo...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT07062094 · Boston Scientific Corporation Not Applicable · 4 countries Recruiting
Recruiting Not Applicable Est. completion 7 April 2028
🇨🇿 CZ🇫🇷 FR🇪🇸 ES🇬🇧 GB

**Who might be able to join this trial:** - People who are 18 years of age or older. - People whose body mass index (BMI — a measure of body weight relative to height) falls within the range required for the device: a BMI of 30–50 for weight loss purposes, or a BMI of 40 or above, or a BMI of 35 or above with other wei...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07065643 · University of Aberdeen Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
🇬🇧 GB

**Who might be able to join this trial:** - Adults over 18 years old who are generally healthy but overweight or obese, with a BMI between 27 and 45 - Women aged 40 or under (15 places available for this group) - Men aged 40 or under (15 places available for this group) - Women aged 55–65 who have been through menopau...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07075146 · José Antonio Mata Marín Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 5 June 2026
🇲🇽 MX

**Who might be able to join this trial:** - Adults aged 18 or older who have a confirmed HIV diagnosis and have never been on HIV treatment (ART) before - People who have signed a form agreeing to take part in the trial - People whose HIV viral load (the amount of HIV in the blood) is at or above 1,000 copies/mL - Peo...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07090005 · Nitinotes Surgical Ltd. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2027
🇺🇸 US

**Who might be able to join this trial:** - People between 21 and 65 years old - People with a body mass index (BMI) between 30 and 50 (a measure of weight relative to height) - People who are willing to make significant changes to their eating habits and lifestyle as required by the study - People who have tried non-...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07091500 · Washington University School of Medicine Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2028
🇺🇸 US

**Who might be able to join this trial:** - People who have obesity, meaning a Body Mass Index (BMI) of 30 or higher - People whose physical ability and movement has been assessed as reduced, based on a specific test called the Modified Physical Performance Test, with a score between 17 and 31 - People whose regular do...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07092228 · New Ismailia National University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 25 September 2025
🇪🇬 EG

Who might be able to join this trial: - Your body mass index (BMI), a measure of body weight relative to height, is 30 or higher - Your waist measurement is more than 80 cm (about 31.5 inches) - You have been diagnosed with polycystic ovarian syndrome (PCOS), a hormonal condition affecting the ovaries - You are between...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07094568 · National and Kapodistrian University of Athens Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2026
🇬🇷 GR

**Who might be able to join this trial:** - Adults between the ages of 30 and 65 years - People with a BMI (body mass index) of 40 or higher, which is a measure of body weight relative to height **Who may not be able to join:** - People who have been diagnosed with Type 1 or Type 2 diabetes - People who have chronic k...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07095426 · Ball State University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2026
🇺🇸 US

Who might be able to join this trial: - People aged between 18 and 55 years old. - People with a BMI of 30 or higher (this requirement is specific to the research goals of the trial). - People who have either 0–1 or 2 or more of the following health markers outside the normal range: blood pressure, blood sugar, triglyc...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07095517 · Massachusetts General Hospital Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 31 March 2027
🇺🇸 US

**Who might be able to join this trial:** - People who are between 18 and 50 years old at the time of joining the trial - People with a Body Mass Index (BMI) — a measure of body weight relative to height — between 27 and 40 - People who had a colonoscopy (a camera examination of the bowel) within the past 9 months - P...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07098780 · Patel Hospital, Pakistan Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 31 July 2025
🇵🇰 PK

Who might be able to join this trial: - People who are 18 years of age or older - People who are having a type of weight-loss surgery called Laparoscopic Sleeve Gastrectomy or Mini Gastric Bypass (MGB) - People who have been diagnosed with severe obesity (also called morbid obesity) Who may not be able to join: - Peop...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT07102251 · Sunshine Lake Pharma Co., Ltd. Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 31 December 2026
🇨🇳 CN

Who might be able to join this trial: **Single Ascending Dose (SAD) group — for healthy adults:** - People who are willing to take part, understand what the study involves, and are able to sign a consent form - Healthy adults aged 18 to 45 years, of any sex - Men who weigh at least 50 kg and women who weigh at least 4...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07103382 · Second Xiangya Hospital of Central South University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇨🇳 CN

**Who might be able to join this trial:** *For people who are obese (without diabetes):* - Adults between 18 and 60 years old, of any sex or gender - People with a Body Mass Index (BMI) of 28.0 or higher (BMI is a number calculated from height and weight) *For people who are overweight or obese and have type 2 diabet...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07119658 · Indiana University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇺🇸 US

Who might be able to join this trial: - Adults aged 18 or older who are able to walk and have come to an emergency department - People with a Body Mass Index (BMI) of 30 or higher (this is a measure of body weight relative to height, and a BMI of 30 or above is generally considered to be in the obese range) - People wh...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07120516 · Sandra Andrusaityte Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇱🇹 LT

**Who might be able to join this trial:** - Children who are between 12 and 16 years old - Children who attend VDU Atžalynas Progymnasium school in Kaunas, Lithuania - A parent or legal guardian must agree in writing, and the child must also agree to take part - The child must be willing to answer questionnaires, have...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07120802 · Harokopio University Not Applicable · 7 countries Recruiting
Recruiting Not Applicable Est. completion 30 September 2025
Cyprus🇫🇷 FR🇬🇷 GR🇵🇱 PL🇵🇹 PT🇪🇸 ES🇸🇪 SE

**Who might be able to join this trial:** - Adults between 18 and 65 years of age - People with a BMI of 25 or above (considered overweight or obese), or people with a BMI between 18.5 and 24.9 (considered normal weight) - People who are willing and able to use a wearable device and a mobile app on an Android phone fo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07134335 · The United Bio-Technology (Hengqin) Co., Ltd. Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 11 July 2030
🇨🇳 CN

**Who might be able to join this trial:** - People aged 18 to 75 years old (inclusive) with a body mass index (BMI) of 24 or above — any gender may apply - People whose kidneys are working at a reduced but not severely low level, based on a specific kidney function measurement called eGFR (between 45 and below 90 mL/m...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07141342 · Jonathan Pearlman Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2027
🇺🇸 US

Who might be able to join this trial: - Adults aged 18 and older who live within approximately 75 miles of Pittsburgh - People who use a wheelchair as their main way of getting around - People who get in and out of bed every night, or most nights - People who have been diagnosed as overweight or obese and want to lose...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07142707 · MBX Biosciences Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 30 October 2026
🇺🇸 US

Who might be able to join this trial: - People who are older than 18 and up to 65 years of age at the time of signing the consent forms. - People with a BMI between 30 and just under 50 kg/m² at the screening and baseline appointments. - People whose weight has been stable for at least 3 months before screening, meanin...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07144098 · Gan & Lee Pharmaceuticals. Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 12 July 2026
🇨🇳 CN

Who might be able to join this trial: - People who fully understand what the study involves, including its procedures and possible risks, and are willing to follow the study rules and sign a consent form. - Adults aged 18 to 75 years old at the time of signing the consent form. - People who weigh at least 50 kg (if ma...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07144800 · Memorial Sloan Kettering Cancer Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 July 2030
🇺🇸 US

Who might be able to join this trial: **Phase 1 (Adult participants)** - People aged 18 or older - People who identify as Hispanic or Latino - People who have sought or used services at the VDS or MHU (confirm with trial site for details on these services) - People who are a parent or primary caregiver for at least on...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07150962 · Fujian Shengdi Pharmaceutical Co., Ltd. Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 1 February 2026
🇨🇳 CN

Who might be able to join this trial: - People who are able to understand the trial procedures and possible side effects, and are willing to sign a written consent form - Male participants aged 18 to 55 years old at the time of signing the consent form - People with a body weight of at least 65 kg and a body mass index...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07151105 · Ohio State University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2026
🇺🇸 US

**Who might be able to join this trial:** - You speak English - You are a man or woman between 18 and 50 years old - Your body mass index (a measure of body weight relative to height) is between 30 and 40 - Your resting blood pressure is below 140/90 mmHg (considered a normal or acceptable range) - You have not taken a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07155564 · University of Leipzig Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 January 2029
🇩🇪 DE

**Who might be able to join this trial:** - People who are able to understand and agree to take part in the study, and provide written consent - People who are generally healthy with no significant medical conditions - People who are physically able to do moderate exercise on a stationary bike - Women whose menstrual c...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07159386 · Medical University of South Carolina Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2030
🇺🇸 US

Who might be able to join this trial: - People who have been diagnosed with MASLD (a type of liver condition related to fat buildup) - People who also have type 2 diabetes (confirm with trial site for full details on this criterion) - Healthcare providers (doctors, physician assistants, and nurse practitioners) who are...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07159971 · Claudia Teresa Tovar Palacio Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 May 2027
🇲🇽 MX

**Who might be able to join this trial:** - Families with a child between 5 and 9 years old - Children who are not currently receiving any medical or nutritional treatment for obesity - Children who are classified as normal weight, overweight, or obese based on World Health Organization growth charts - Children whose...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07165548 · Clinica Universidad de Navarra, Universidad de Navarra Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 May 2026
🇪🇸 ES

**Who might be able to join this trial:** - People of any gender between 18 and 65 years old - People with a BMI between 27.0 and 39.9 kg/m² (classified as grade II overweight or obesity) - People whose general physical health check and vital signs (such as blood pressure and heart rate) are normal or not relevant to...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07169136 · Nemours Children's Clinic Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇺🇸 US

Who might be able to join this trial: - People diagnosed with Polycystic Ovary Syndrome (PCOS) based on specific criteria: irregular periods (cycles shorter than 21 days or longer than 35 days) and higher-than-normal male hormone levels, confirmed by blood tests. - People who are classified as obese, meaning their weig...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07183228 · Eatit AB Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2026
🇸🇪 SE

**Who might be able to join this trial:** - You are 18 years of age or older - Your Body Mass Index (BMI — a measure based on your height and weight) is 30 or above - Your BMI is between 27 and 30, AND at least one of the following applies: you have previously been told by a doctor that you have obesity; you have one...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07190170 · NYU Langone Health Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2028
🇺🇸 US

Who might be able to join this trial: - People who have lost at least 5% of their body weight through non-surgical means in the last 3 months. - People with a BMI (body mass index) between 20.5 and 45 kg/m². - People aged between 25 and 65 years old. - People who own a smartphone, or who are willing to use one if the t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07207772 · Jianbo Wu Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇨🇳 CN

**Who might be able to join this trial:** - People aged between 18 and 65 years - People who are planning to have weight-loss (bariatric) surgery using keyhole (laparoscopic) techniques under general anaesthetic - People with a general health rating assessed by an anaesthetist as falling within a standard low-to-moder...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07209202 · Touro University, California Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2030
🇺🇸 US

Who might be able to join this trial: - People with a BMI between 30 and 38 (the obese group) or a BMI between 19 and 25 (the lean group) Who may not be able to join: - People who have been pregnant or breastfeeding in the past six months - People who have Type 1 or Type 2 diabetes, or whose blood sugar or related tes...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07216820 · University of North Carolina, Chapel Hill Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2027
🇺🇸 US

**Who might be able to join this trial:** - Adults aged 18 or older - People with a body mass index (BMI) of 35 or higher, measured at a pre-surgery clinic visit - People scheduled for a planned (non-emergency) shoulder surgery on one side — such as shoulder scope, shoulder replacement, rotator cuff repair, or reverse...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07218588 · Nemours Children's Clinic Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2026
🇺🇸 US

Who might be able to join this trial: - People who receive care at the Nemours TJU Primary Care Clinic - Young people aged 12 to 17 years old at the time of joining the trial - Young people whose body weight falls at or above the 85th percentile for their age and height (a measure used to assess weight relative to othe...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07219589 · Hanmi Pharmaceutical Company Limited Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 1 March 2027
🇺🇸 US

**Who might be able to join this trial:** - Adults between 18 and 65 years of age. - **Part A only:** People who are generally healthy with a BMI between 20 and 27 at the time of screening. - **Part B only:** People who are generally healthy and have obesity, with a BMI between 30 and 45 at the time of screening. - Pe...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07220772 · Regeneron Pharmaceuticals Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 18 June 2027
🇩🇪 DE

**Who might be able to join this trial:** - People who have a confirmed medical record showing they carry non-working (loss of function) copies of the LEP gene inherited from both parents, documented before the screening visit - People who have been assessed as having class 2 or higher obesity (a specific level of obes...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07220954 · AstraZeneca Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 9 September 2026
🇬🇧 GB

**Who might be able to join this trial:** - Men, or women who are not pregnant and not breastfeeding, between 18 and 55 years old - People with a body mass index (a measure of body weight relative to height) between 25.0 and 35.0, and who weigh at least 50 kg **Who may not be able to join:** - People with a history of...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07221279 · Kennesaw State University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 August 2027
🇺🇸 US

**Who might be able to join this trial:** - People aged 20 years or older - Adults who are otherwise healthy but take prescription medication to manage high blood pressure or osteoarthritis (joint disease) - People who are not regularly active, or who only walk for activity, and have not followed a structured exercise...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07223151 · Nana Gletsu Miller Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2027
🇺🇸 US

**Who might be able to join this trial:** - Teenagers aged 12 to 18 who tend to prefer sweeter drinks, specifically those who identify a higher-sugar drink (at a concentration of 10.3% sucrose or above) as their favourite among samples tested - Teenagers who have obesity, defined as a body mass index (BMI) above the 95...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07225816 · Novo Nordisk A/S Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 13 December 2026
🇺🇸 US

**Who might be able to join this trial:** - Adults aged 18 or older at the time of signing the consent form - People with a body mass index (a measure of body weight relative to height) between 25.0 and 45.0, where the extra weight is due to excess body fat, as assessed by the study doctor - People with type 2 diabetes...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07228130 · The Miriam Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2029
🇺🇸 US

**Who might be able to join this trial:** - People who are fluent in English and can read and write at around a 6th-grade level - People with a Body Mass Index (BMI) above 25 (a number calculated from height and weight that indicates a person may be carrying extra weight) - People who are able to walk the length of two...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07228741 · St. Jude Children's Research Hospital Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 November 2027
🇺🇸 US

Who might be able to join this trial: - People who were diagnosed with acute lymphoblastic leukemia (a type of blood cancer) and treated with chemotherapy only, at least 5 years ago - People who finished their cancer treatment at least 2 years ago - People who test negative for pregnancy at the start of the trial (if f...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07229027 · Medialis Ltd. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2026
🇬🇧 GB

**Who might be able to join this trial:** **If joining as a patient:** - People who are 18 years of age or older at the time of completing the survey - People with a self-reported BMI over 25 - People who are willing to take part in all study activities - People who can read, write, and hold a conversation in English...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07229170 · San Raffaele Telematic University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2027
🇮🇹 IT

Who might be able to join this trial: - Adults between 18 and 60 years of age who have been diagnosed with obesity - People who are currently being treated with a GLP-1 receptor agonist medication, such as semaglutide or tirzepatide (weight management injections) - People who have at least 12 weeks of medical records a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07229508 · State University of New York at Buffalo Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2030
🇺🇸 US

Who might be able to join this trial: - Children (both boys and girls) are being considered for this trial - Children from Black, Indigenous, People of Color (BIPOC), or Hispanic families - Children from lower-income households, which the trial defines based on the household's level of education and whether the family...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07236788 · China-Japan Friendship Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2026
🇨🇳 CN

**Who might be able to join this trial:** - Men with a haemoglobin (a measure of red blood cell health) level between 10 and 14 g/dL, or women with a level between 10 and 13 g/dL, at the start of the trial - People whose iron levels are low, specifically with a ferritin level (a measure of iron stores) below 100 μg/L a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07243171 · Hangzhou Sciwind Biosciences Co., Ltd. Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 3 August 2026
🇨🇳 CN

**Who might be able to join this trial:** - Your Body Mass Index (BMI) must be between 24.0 and 35.0 at the time of joining, AND you must weigh more than 60 kg (about 132 lbs) if male, or more than 50 kg (about 110 lbs) if female - Your body weight must not have changed by more than 5% in the 3 months before joining (s...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07244445 · Ian J. Neeland, MD Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
🇺🇸 US

Who might be able to join this trial: - People with a body weight classified as obese (a BMI of 30 or higher), or people with a BMI of 27 or higher who also have at least one health condition related to excess weight, who have been taking semaglutide or tirzepatide continuously for three months for a medical reason and...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07245979 · Poznan University of Life Sciences Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 November 2026
🇵🇱 PL

Who might be able to join this trial: - People who are female - People between the ages of 40 and 65 years old - People with a BMI (a measure of body weight relative to height) above 25, which is considered overweight or obese Who may not be able to join: - People who are male - People with a BMI below 25 - People who...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07247409 · Chinese University of Hong Kong Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
Hong Kong

Who might be able to join this trial: - People who have been diagnosed with Type 2 diabetes - People with a body mass index (BMI) of 27.5 or higher, and/or a waist measurement of 80cm or more (for women) or 90cm or more (for men) - People aged between 18 and 50 years old - People who are comfortable using a smartphone...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07255209 · Innovent Biologics (Suzhou) Co. Ltd. Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 31 October 2027
🇨🇳 CN

**Who might be able to join this trial:** - People who are aged 12 years or older but under 18 years old at the time of signing the consent forms - People whose BMI meets the obesity definition set out in the Chinese standard "WS/T 586-2018" for school-age children and adolescents, OR people whose BMI meets the overwe...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07261475 · University of Primorska Early Phase 1 · 1 country Recruiting
Recruiting Early Phase 1 Est. completion 1 June 2026
🇸🇮 SI

Who might be able to join this trial: - People with a body mass index (BMI) over 30 kg/m², which is classified as Class I obesity - People with prediabetes, meaning fasting blood sugar levels between 6.1 and 6.9 mmol/L Who may not be able to join: - People with diseases affecting the digestive system or gut - People w...

Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.
NCT07262762 · Cinnagen Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
Iran

**Who might be able to join this trial:** - You are 18 years of age or older (male or female) - You are willing to read and sign a consent form agreeing to take part in the study - Your body mass index (a measure of body weight relative to height) is 30 or above, OR it is 27 or above and you have at least one health co...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07272824 · Turku University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 January 2026
🇫🇮 FI

Who might be able to join this trial: - Women who were pregnant and had a body weight classified as obese (a BMI of 30 or higher) before becoming pregnant - Women who are able to use a digital care system and an electronic maternity record Who may not be able to join: - Women who would have significant difficulty taki...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07276412 · Universidad de Extremadura Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 24 July 2026
🇪🇸 ES

Who might be able to join this trial: - Children who are currently attending primary school in the Extremadura region. Who may not be able to join: - Children who have been diagnosed with special educational needs. - Children who would be joining the programme after it has already begun. - Children whose parents or le...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07288294 · Rush University Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2028
🇺🇸 US

**Who might be able to join this trial:** - People who have been prescribed liraglutide, semaglutide, tirzepatide, or a newer FDA-approved long-term obesity medication for weight management by a primary care provider at Rush University System for Health, and who have already taken at least one dose of that medication a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07289555 · El-Sahel Teaching Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇪🇬 EG

Who might be able to join this trial: - Adults between 18 and 65 years old. - People with a body mass index (BMI) of 35 or higher, or a BMI of 30 or higher combined with a weight-related health condition such as type 2 diabetes, high blood pressure, high cholesterol, obstructive sleep apnea, or fatty liver disease. - P...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07292389 · University of Virginia Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2027
🇺🇸 US

**Who might be able to join this trial:** - Adults aged 18 years or older - People with a Body Mass Index (BMI) of 25.0 or higher (a measure of body weight relative to height) - People who weigh 175 kg (approximately 386 lbs) or less, due to the study scale's weight limit - People who own a smartphone that works with t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07293325 · Second Affiliated Hospital, School of Medicine, Zhejiang University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 2 April 2027
🇨🇳 CN

**Who might be able to join this trial:** - Adults between 18 and 75 years old - People diagnosed with obesity based on a BMI of 30 or higher - People who have not used any weight-loss medications (including GLP-1 drugs, tirzepatide, or metformin taken for weight loss) in the past 3 months - People who are able and wil...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07294950 · Mount Sinai Hospital, Canada Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 September 2028
🇨🇦 CA

Who might be able to join this trial: - People who have been diagnosed with a BMI of 30 or higher, or a BMI of 27 or higher along with a weight-related health condition such as osteoarthritis, non-alcoholic liver disease, sleep apnea, or high blood pressure — and who do not have heart disease or type 2 diabetes. - Peop...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07296861 · UNC Lineberger Comprehensive Cancer Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2027
🇺🇸 US

Who might be able to join this trial: **For adults (caregivers):** - The adult must be able to give their own informed agreement to take part in the study - The adult must be 18 years of age or older - The adult must be the main caregiver of a child with Down syndrome who is between 2 and 6 years old - The adult must...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07296900 · University of Ulm Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2075
🇩🇪 DE

Who might be able to join this trial: - People who have been diagnosed with a genetic form of obesity confirmed through genetic testing, where the genetic variant is classified at a certain level of certainty (known as ACMG classification 3–5, linked to obesity), and/or people who developed severe obesity very early in...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07297290 · University Of Nigeria Teaching Hospital Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 31 March 2027
Nigeria

Who might be able to join this trial: - People with a body mass index (BMI) of 30 or higher, which is the medical measure used to classify obesity - People whose fasting blood sugar level is below 7.0 mmol/L (a blood sugar reading taken after not eating for a period of time) - People who have not used any prescribed or...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07299942 · University of Glasgow Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 January 2025
🇬🇧 GB

Who might be able to join this trial: - Women who are overweight or obese, with a BMI between 25 and 39.9. - People aged between 18 and 60 years old. - People whose weight has been stable for at least 3 months before the study begins. Who may not be able to join: - People who smoke. - People who have an irregular mens...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07312344 · Mahidol University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 January 2026
🇹🇭 TH

**Who might be able to join this trial:** - People who are between 25 and 45 years old - People who are Thai nationals - People who are able to walk and carry out everyday activities on their own, without using any walking aids or assistive devices - People whose Body Mass Index (BMI) falls between 25 and 35 (a measur...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07313293 · Centre Hospitalier Departemental Vendee Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 2 April 2028
🇫🇷 FR

Who might be able to join this trial: - Adults (18 years of age or older) - People who are scheduled to have a sleeve gastrectomy (a type of weight-loss surgery that removes part of the stomach) - People who are able to understand the study and have given verbal agreement to take part - People who are covered by, or en...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07315282 · Nicole Stoffel Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2026
🇱🇧 LB

**Who might be able to join this trial:** - People with a body mass index (BMI) of 27.5 or higher (a measure of body weight relative to height) - People with low iron stores in the blood, based on a specific blood test result (serum ferritin below 30 μg/L) - People whose blood has a haemoglobin level of 11 g/dL or abov...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07316179 · Antalya Training and Research Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
Turkey (Türkiye)

**Who might be able to join this trial:** - Adults between the ages of 18 and 65 years - People classified as ASA physical status II or III, meaning they have a mild to moderate ongoing health condition (confirm with trial site) - People who are scheduled to have planned weight-loss (bariatric) surgery under general an...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07316816 · Stanford University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2030
🇺🇸 US

Who might be able to join this trial: - People who have Class 2 or Class 3 obesity (these are medical categories based on body weight) - People who are already part of the Adolescent Bariatric Program at Stanford Children's, where the treating team has determined that either a sleeve gastrectomy surgery or a GLP-1 medi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07324447 · Hospitales Universitarios Virgen del Rocío Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
🇪🇸 ES

**Who might be able to join this trial:** - You are on the waiting list for weight loss surgery (gastric bypass or sleeve surgery) at Hospital Universitario Virgen del Rocío in Seville - You are 18 years of age or older - You are considered able to take part in physical exercise - You are willing and able to sign a con...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07325500 · The University of Texas Health Science Center, Houston Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 31 May 2028
🇺🇸 US

**Who might be able to join this trial:** - People who have a confirmed diagnosis of HIV-1 (a specific type of HIV). - People who have been on HIV treatment (antiretroviral therapy) for at least 24 weeks before joining, with no changes to that treatment in the past 12 weeks and no planned changes during the study. - P...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07330297 · I.M. Sechenov First Moscow State Medical University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇷🇺 RU

**Who might be able to join this trial:** This trial has three separate groups. People may be considered for one of the following: **Group 1 – Metabolic Syndrome:** - Adults over 18 years old who have been diagnosed with Metabolic Syndrome, meaning a large waist measurement (over 94 cm for men, over 80 cm for women)...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07331389 · Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 12 January 2026
🇨🇳 CN

**Who might be able to join this trial:** - People who are considered to be in good general health based on their medical history, blood tests, vital signs, heart tracing (ECG), and physical examination during the screening period - People between the ages of 18 and 45 (inclusive), of any gender - People who weigh at...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07332273 · Fundación Pública Andaluza para la Investigación de Málaga en Biomedic... Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 November 2026
🇪🇸 ES

Who might be able to join this trial: - Adults between 25 and 60 years of age - People with a body mass index (BMI) between 30.0 and 39.9, which falls into the obesity grade I–II range - People who have either mildly underactive thyroid function (with a specific hormone level called TSH between 5 and 10, but other thyr...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07335731 · China-Japan Friendship Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 April 2027
🇨🇳 CN

**Who might be able to join this trial:** - People who are overweight or obese and meet the medical criteria for weight loss surgery, with a BMI of 27.5 or higher - People who understand what the trial involves, agree to take part willingly, and have signed a consent form **Who may not be able to join:** - People whos...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07341711 · University of Thessaly Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2026
🇬🇷 GR

Who might be able to join this trial: - Your Body Mass Index (BMI) is between 25 and 40 (a measure of body weight relative to height that indicates overweight or obesity range) - You have not done any regular exercise training for at least the past year - You have not followed any special diet or eating plan in the las...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07342855 · University of Texas Southwestern Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2027
🇺🇸 US

Who might be able to join this trial: - Children whose BMI (a measure of body weight relative to height) is at or above the 85th percentile for their age group, as reported by a parent or guardian - Children who are able to take part in physical activity at a level similar to a standard primary school PE class, and who...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07343700 · Arkansas Children's Hospital Research Institute Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2030
🇺🇸 US

**Who might be able to join this trial:** - You are 18 years of age or older - Your BMI (a measure of body weight relative to height) is 30 or above - You are currently not getting the recommended 150 minutes of moderate physical activity (such as brisk walking) per week - Any children born to mothers participating in...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07348601 · ConSynance Therapeutics Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 June 2027
🇺🇸 US

**Who might be able to join this trial:** - People who are generally healthy males or females between the ages of 13 and 50 (inclusive) - People who have a confirmed diagnosis of Prader-Willi Syndrome (PWS) documented in their medical records through genetic testing, and who are in a specific stage of PWS-related eati...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07355738 · Gan & Lee Pharmaceuticals. Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 20 May 2026
🇨🇳 CN

**Who might be able to join this trial:** - You are willing to sign a consent form, can receive injections under the skin, understand what the trial involves, and are able to follow all rules set out in the study. - You are male and between 18 and 50 years old (inclusive) at the time of signing the consent form. - You...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07356310 · University of Rochester Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2027
🇺🇸 US

Who might be able to join this trial: - People who are willing to do a breathing test as part of the trial - People who can speak and understand English - People who have been referred by their doctor for a specific type of breathing test called a Methacholine Challenge Test Who may not be able to join: - People who a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07359261 · University of Alberta Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 31 December 2026
🇨🇦 CA

**Who might be able to join this trial:** - You are 18 years of age or older - Your body weight falls into the category classified as obese (a BMI of 30 or higher) - You are currently on a breathing machine (ventilator) that is doing all the breathing for you - You have been on the breathing machine for less than 24 ho...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07359625 · University of Aarhus Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2027
🇩🇰 DK

Who might be able to join this trial: - People who are between 55 and 70 years old - People with a body mass index (a measure of body weight relative to height) between 25 and 35 Who may not be able to join: - People who have any short-term or long-term health conditions that the trial investigators believe could affe...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07363616 · The Miriam Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 November 2026
🇺🇸 US

Who might be able to join this trial: - People who are 18 years of age or older - People with a BMI between 25 and 40, noting that a BMI between 25 and 30 also requires the presence of at least one additional health condition such as high blood pressure, high cholesterol, prediabetes, or type 2 diabetes Who may not be...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07364175 · Cambridge University Hospitals NHS Foundation Trust Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2027
🇬🇧 GB

**Who might be able to join this trial:** - People aged between 18 and 40 years old (inclusive) - People with a BMI of 27 or higher - People who have been diagnosed with primary (essential) high blood pressure, as defined by NICE guidelines - People whose blood pressure readings (measured without a clinician present)...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07368777 · Metropolitan College Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2027
🇬🇷 GR

**Who might be able to join this trial:** - Adults aged 18 or older - People with a Body Mass Index (BMI) of 25 or higher (this means a person is considered to be in the "overweight" or above range — the trial site can confirm what this means for a specific situation) - People who speak Greek and are able to read and u...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07368881 · University of Liverpool Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2026
🇬🇧 GB

Who might be able to join this trial: - People who are able to place and pay for a takeaway pizza order for delivery today or tomorrow - People who currently live in a select postcode area covered by one of three store locations: Manchester (postcodes M1–M5, M11–M16, M18, M19), Liverpool (postcodes L1–L6, L8, L13, L15)...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07372157 · Marmara University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
Turkey (Türkiye)

**Who might be able to join this trial:** - People who are willing to volunteer to take part in the study - People with a BMI (a measure of body weight relative to height) between 25 and 35 kg/m² - People who have not had any surgical operation in the past 6 months **Who may not be able to join:** - People who have a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07372729 · Beijing Anzhen Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 24 September 2026
🇨🇳 CN

Who might be able to join this trial: - People aged 18 or older, of any gender - People who are overweight or obese, defined as having a Body Mass Index (BMI) between 24.0 and 32.4, or a waist measurement of 90 cm or more (men) or 85 cm or more (women) - People who have at least one of the following borderline health c...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07372846 · Samsun University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2026
Turkey (Türkiye)

Who might be able to join this trial: - The procedure will involve general anesthesia (being fully asleep during surgery) - A body mass index (BMI) of 30 or higher, which doctors classify as obese - The person has agreed to take part and signed a consent form Who may not be able to join: - People who are currently pre...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07382908 · BrightGene Bio-Medical Technology Co., Ltd. Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 12 February 2026
🇨🇳 CN

**Who might be able to join this trial:** - People aged 18 to 55 years old (inclusive) - Men who weigh at least 50 kg, or women who weigh at least 45 kg, and whose BMI falls in the overweight range (24.0 to below 28.0) or obese range (28.0 or above) - People who do not plan to become pregnant (or cause a partner to bec...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07395960 · Fudan University Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 30 September 2026
🇨🇳 CN

**Who might be able to join this trial:** - People who are between 60 and 75 years old - People with a body mass index (a measure of body weight relative to height) of 24 or higher - People whose recent blood sugar control test (called glycated hemoglobin, or HbA1c) shows a result below 8.5% - People whose score on a...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07395973 · Maastricht University Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 October 2027
🇳🇱 NL

**Who might be able to join this trial:** - People who are between 60 and 80 years old - People with a body mass index (BMI) between 25 and 35 (a measure of body weight relative to height — confirm with trial site if unsure) - People who do less than 2 hours of organised physical activity per week and have been living...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07397572 · Cairo University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2026
🇪🇬 EG

Who might be able to join this trial: - Adults between 18 and 65 years old who are already scheduled to have a type of weight-loss surgery called laparoscopic sleeve gastrectomy (a procedure that reduces the size of the stomach using keyhole surgery). - People who are able to understand the study information and agree...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07399678 · Alveus Therapeutics, Inc. Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 1 April 2027
🇺🇸 US

Who might be able to join this trial: - Adults between 18 and 65 years old (male or female) who can give their consent to participate - People with a Body Mass Index (BMI) between 27.0 and 39.9, where the extra weight is due to body fat (as confirmed by the study doctor) - People whose weight has been stable, meaning t...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07402031 · Université Catholique de Louvain Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2032
🇧🇪 BE

**Who might be able to join this trial:** - You are between 18 and 65 years old - You have obesity and have been assessed by a medical team who recommend weight-loss surgery as a treatment option - You are in good overall physical and mental health and are able to give informed consent to take part - You are a French s...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07404839 · University of Utah Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2030
🇺🇸 US

Who might be able to join this trial: **For communities:** - Any community is welcome to apply by submitting a letter of intent and a short description of their local needs. - Communities where preventing and treating childhood obesity is considered an important health concern are given priority. - Communities and loc...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07406295 · Florida State University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
🇺🇸 US

**Who might be able to join this trial:** - People with a Body Mass Index (BMI) of 30 or higher (a measure of body weight relative to height) - Women with a waist measurement of 88 cm or more, or men with a waist measurement of 102 cm or more **Who may not be able to join:** - People whose body weight has changed by m...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07409064 · Children's Hospital Medical Center, Cincinnati Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2028
🇺🇸 US

Who might be able to join this trial: - People between the ages of 10 and 20 years old - People with a BMI of 30 or higher, or a BMI at or above the 95th percentile for their age and sex (a measure of body weight relative to height — confirm with trial site if unsure which applies) - People who are planning to start th...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07428187 · University of Colorado, Denver Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 March 2028
🇺🇸 US

**Who might be able to join this trial:** - People who are between 25 and 45 years old - People with a Body Mass Index (BMI) of 27 or higher (BMI is a measure based on height and weight) - People who are comfortable taking part in a weight-loss program - People who are willing to eat a daily snack of either walnuts or...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07429136 · Amsterdam University of Applied Sciences Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2026
🇳🇱 NL

Who might be able to join this trial: - People aged 55 or older. - People who are classified as obese, meaning a BMI over 30, or a BMI over 27 combined with a waist measurement above 88 cm for women or 102 cm for men. - People who live independently at home, not in a hospital, nursing home, or other health facility. -...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07430111 · Ankara Etlik City Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 5 February 2027
Turkey (Türkiye)

Who might be able to join this trial: - Adults between 18 and 65 years old - People with a Body Mass Index (BMI) of 30 or higher (this means a person's weight falls into the category doctors classify as obese) - People with an ASA physical status rating of II or III — this is a score doctors use to describe overall hea...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07431593 · University of Rijeka Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 28 April 2027
🇭🇷 HR

Who might be able to join this trial: - Adults aged 18 or older - People with a body weight in the overweight range (BMI between 25.0 and 29.9) or in the obesity range (BMI of 30 or above) - People who are able to attend scheduled visits at the trial site - People who are willing to sign a consent form agreeing to take...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07437430 · McMaster University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇨🇦 CA

Who might be able to join this trial: - People between the ages of 20 and 80 years old - People with a body mass index (BMI) between 30 and 39 (a measure of body weight relative to height, indicating obesity) - People who are willing and able to follow the study's instructions and procedures - People who are able to gi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07440147 · FH Joanneum Gesellschaft mbH Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2027
🇦🇹 AT

Who might be able to join this trial: - People who work in healthcare or an industrial setting and do shift work. - People who are employed or self-employed and work at least 24 hours per week. - People whose current work schedule regularly includes at least 3 hours of work between midnight and 5:00 am, on at least 2 n...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07443059 · Beijing QL Biopharmaceutical Co.,Ltd Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 3 December 2026
🇨🇳 CN

**Who might be able to join this trial:** - People who are able to understand the trial procedures and possible side effects, and are willing to sign a written consent form. - People aged between 18 and 75 years old at the time of signing the consent form. - People with a body mass index (BMI) between 19.0 and 32.0, a...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07445503 · University of Peloponnese Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2027
🇬🇷 GR

**Who might be able to join this trial:** - Adults between 18 and 80 years of age - People who are overweight or obese, meaning a body mass index (BMI) above 25, or a waist measurement greater than 94 cm for men or 80 cm for women - People who have at least one of the following: high triglycerides (a type of fat in th...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07446439 · Vanda Pharmaceuticals Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 December 2026
🇺🇸 US

Who might be able to join this trial: - People with a Body Mass Index (BMI) of 25 or above but below 40 (a measure of body weight relative to height) - People who do not have serious medical problems or chronic diseases, and specifically do not have type 1 or type 2 diabetes Who may not be able to join: - People who h...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07446972 · Cairo University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇪🇬 EG

**Who might be able to join this trial:** - Women who are female and between 18 and 45 years old (of childbearing age) - People with a Body Mass Index (BMI) of 40 or above, or a BMI of 35 or above along with health conditions related to obesity, meeting the standard international guidelines for weight-loss surgery - Pe...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07447440 · Clinica Universidad de Navarra, Universidad de Navarra Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 November 2027
🇪🇸 ES

**Who might be able to join this trial:** **Healthy Participants:** - People who have been postmenopausal for at least one year - People who are a normal weight, overweight, or obese - People with no personal history of cancer - People whose weight has been stable (within 5%) over the last three months - People who ar...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07448090 · Hubei Hospital of Traditional Chinese Medicine Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 July 2028
🇨🇳 CN

**Who might be able to join this trial:** - People aged 18 or older, of any gender - People whose weight has stayed relatively stable (changed by no more than 5%) over the past 3 months, and whose body mass index (BMI) is 28.0 or higher - People who are willing to attend follow-up appointments and follow the study guid...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07457437 · University of Exeter Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
🇬🇧 GB

**Who might be able to join this trial:** - Women between 25 and 50 years old - People with a BMI of 30 or above (up to 35), or a BMI of 27 or above alongside at least one health condition related to excess weight **Who may not be able to join:** - People who have previously used a type of medication known as a GLP-1...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07461610 · Cairo University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2026
🇪🇬 EG

**Who might be able to join this trial:** - You are between 18 and 60 years old - Your Body Mass Index (BMI) is 40 or higher, OR your BMI is 35 or higher AND you have at least one weight-related health condition (such as type 2 diabetes, high blood pressure, high cholesterol, joint problems, or sleep apnea) - You are a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07463495 · University of Aarhus Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇩🇰 DK

Who might be able to join this trial: - People with a Body Mass Index (BMI) between 30 and 45 (a measure of body weight relative to height, indicating obesity) - People who are older than 18 years of age - People whose blood sugar control levels (measured by a test called HbA1c) are below a certain threshold, meaning t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07463846 · Alnylam Pharmaceuticals Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 27 April 2027
🇨🇦 CA

Who might be able to join this trial: - People with a body mass index (BMI) of 30 or above but below 40 (this is a common measure of body weight relative to height) - People with an HbA1c level below 6.5% (this is a blood test result that shows average blood sugar levels over the past few months) Who may not be able t...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07464015 · University of Central Florida Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2027
🇺🇸 US

Who might be able to join this trial: - People who are overweight or obese - People who attend a pediatric (children's) clinic - People who have Medicaid insurance coverage Who may not be able to join: - There are no listed exclusion criteria for this trial Important: Always verify eligibility with the trial site dir...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07465341 · University of Michigan Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2028
🇺🇸 US

**Who might be able to join this trial:** - Your Body Mass Index (BMI) is 30 or higher (this is a measure of body weight relative to height) - You have been diagnosed with at least one weight-related health condition, such as: Type 2 Diabetes, Prediabetes, High Cholesterol, High Blood Pressure, Polycystic Ovary Syndrom...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07465965 · Shanghai World Leader Pharmaceutical Co., Ltd. Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 21 August 2026
🇺🇸 US

Who might be able to join this trial: - Adults between 18 and 65 years old (male or female) - People with a Body Mass Index (BMI) between 27.0 and 35.0 kg/m² at the time of screening - People whose weight has stayed within 5% (up or down) over the 3 months before screening, using only diet and exercise (self-reported)...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07467694 · Joslin Diabetes Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2030
🇺🇸 US

Who might be able to join this trial: - People who are between 18 and 45 years old at the time of joining the trial - People whose body weight (BMI) before pregnancy or in the first three months of pregnancy was in the range of 18.5 to 40 kg/m² - People carrying a single baby with no pregnancy complications - People wh...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07470749 · Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2026
Bangladesh

Who might be able to join this trial: - Adults aged 18 years or older - People who live in the selected community where the trial is taking place Who may not be able to join: - People who are currently pregnant - People who have a severe illness that would prevent participation, such as paralysis, being bedridden, or...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07477704 · Regeneron Pharmaceuticals Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 29 December 2026
🇺🇸 US

Who might be able to join this trial: - People who have a higher-than-normal level of LDL cholesterol (often called "bad" cholesterol), as measured according to the trial's specific guidelines (confirm with trial site) Who may not be able to join: - People who are planning to start or change the dose of any medication...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07479498 · Paul Estabrooks Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 29 September 2029
🇺🇸 US

Who might be able to join this trial: - A family that includes a parent or legal caregiver and at least one child between the ages of 5 and 12 - The child must have been identified through health record data from a clinic that is taking part in the trial - The child must have had at least one visit at the participatin...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07482436 · Trabzon Kanuni Education and Research Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2026
Turkey (Türkiye)

**Who might be able to join this trial:** - You have agreed to take part and given your consent - You had surgery that was performed under general anesthesia (fully asleep during the operation) - You are 18 years of age or older - Your overall health before surgery was rated by your anesthesiologist as fitting into one...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07493356 · Sindh Institute of Urology and Transplantation Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 8 September 2026
🇵🇰 PK

**Who might be able to join this trial:** - Adults between 18 and 60 years old (male or female) - People with a body mass index (BMI) of 30 or higher (considered obese by standard medical classification) - People rated as having a moderate level of health risk for surgery, based on a standard anaesthesia assessment sca...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07501377 · Max Planck Institute for Human Cognitive and Brain Sciences Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2029
🇩🇪 DE

Who might be able to join this trial: - Women who are in a specific stage of the transition toward menopause, known as the late reproductive or early menopausal transition stage (confirm with trial site for exact staging) - People with a body mass index (a measure of body weight relative to height) above 25, or a waist...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07506369 · University Hospital, Gentofte, Copenhagen Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2026
🇩🇰 DK

**Who might be able to join this trial:** - People who are male - People who are between 18 and 65 years old at the time of joining - People whose body mass index (a measure of body weight relative to height) falls between 18 and 27 - People whose body fat percentage is below 20% - People who are willing and able to gi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07508020 · Novo Nordisk A/S Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 19 January 2028
🇩🇪 DE

Who might be able to join this trial: - People who were male or female at birth - People aged 18 to 64 years old at the time of signing the consent form - People whose overall health, physical check-up, heart trace, and blood test results are considered acceptable by the trial doctor at the screening visit - People who...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07511205 · AstraZeneca Phase 1 · 2 countries Recruiting
Recruiting Phase 1 Est. completion 9 April 2027
🇬🇧 GB🇺🇸 US

**Who might be able to join this trial:** - Female participants must have a negative pregnancy test at the screening visit and at the time of admission to the clinic. - Female participants who cannot become pregnant must be confirmed as postmenopausal, or have records showing they have had a hysterectomy, removal of b...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07514260 · AbbVie Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 1 January 2027
🇺🇸 US

Who might be able to join this trial: - People who are Japanese, either first-generation (born in Japan, with both parents and all four grandparents also born in Japan of full Japanese descent) or second-generation (born outside Japan, but with both parents and all four grandparents born in Japan of full Japanese desce...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07517042 · Shanghai Zhongshan Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2028
🇨🇳 CN

**Who might be able to join this trial:** - Adults aged 18 or older - People with a body mass index (BMI) between 28.0 and 45.0 kg/m² due to simple obesity (not caused by another medical condition) - People who are able and willing to sign a consent form agreeing to take part **Who may not be able to join:** - People...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07520929 · University of Prince Edward Island Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 December 2026
🇨🇦 CA

Who might be able to join this trial: - People who are between 30 and 55 years old - People with a body mass index (a measure of body weight relative to height) of 27 or above - People with a waist measurement greater than 102 cm (for men) or greater than 88 cm (for women) - People who have a reliable way to travel to...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07527195 · Novo Nordisk A/S Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 28 April 2028
🇩🇰 DK

Who might be able to join this trial: - People who are male or female, aged between 50 and 70 years old at the time of signing the consent form. - People whose Body Mass Index (BMI) — a measure based on height and weight — falls between 30.0 and 39.9 at the initial screening visit. - People whose excess body weight is...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07528027 · Shandong Suncadia Medicine Co., Ltd. Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 December 2027
🇨🇳 CN

Who might be able to join this trial: - People aged between 18 and 70 years old on the day they sign the consent form, of any gender. - People whose blood pressure readings at screening or randomisation fall within a specific elevated range — either the top number (systolic) is between 140 and 169 mmHg with the bottom...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07529119 · Universidad Nacional de Caaguazu Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2026
Paraguay

"Who might be able to join this trial: - Children between 8 and 16 years old from Paraguay may be considered, with the trial looking to include a mix of children with and without excess body weight. Who may not be able to join: - Children who have an allergy to mango or chia may not be eligible to participate. Import...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07529704 · Helena Vall Roqué Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2028
🇪🇸 ES

**Who might be able to join this trial:** - Mothers and/or fathers who are 18 years old or older - People who are the main caregiver of a healthy child between 6 months and 3 years old, where that child was born at or after 37 weeks of pregnancy - Families where at least one parent has overweight or obesity, as measur...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07552727 · Universidad San Sebastián Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇨🇱 CL

Who might be able to join this trial: - People aged 18 to 59 years who live in the Los Ríos Region - People with a body weight classified as overweight or obese (a body mass index, or BMI, above 25) - People who have been diagnosed with a chronic condition such as insulin resistance or type 2 diabetes - People who are...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07559227 · Ball State University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
🇺🇸 US

Who might be able to join this trial: - People aged 18 to 55 years old. - People with a BMI in the healthy range (18.5–24.9) or above 30 (Part 1 of the trial), or people with a BMI above 30 (Part 2 of the trial). - Women who are not pregnant and not planning to become pregnant during the trial. - Women who have not yet...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07565051 · University Hospital, Geneva Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 18 August 2027
🇨🇭 CH

**Who might be able to join this trial:** - You are 18 years old or older - You meet the standard requirements for a type of weight-loss surgery called gastric bypass (RYGB), which includes having a BMI of 35 or above, having tried weight-loss programs without success for at least 2 years (or 1 year if your BMI is 50 o...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07566390 · Novo Nordisk A/S Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 26 November 2026
🇺🇸 US

**Who might be able to join this trial:** - People who are male or female, aged between 18 and 55 years old at the time of signing the consent form - People with a Body Mass Index (BMI) between 25.0 and 34.9, where the higher weight is due to excess body fat, as determined by the study doctor - People who the study doc...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07570758 · ERX Pharmaceuticals Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 May 2027
🇺🇸 US

**Who might be able to join this trial:** - People aged 18 to 60 years old (male or female) who are able to understand and agree to follow the study requirements - People with a body mass index (BMI) between 30 and 50 (a measure of body weight relative to height) - People whose body weight has been stable (less than 5...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07574723 · Dasman Diabetes Institute Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 May 2029
Kuwait

**Who might be able to join this trial:** - Adults aged 18 years or older - People with a body mass index (BMI) of 27 or above at the time of screening, who have tried dieting to lose weight without success - People who have not been diagnosed with diabetes - People who are able to read, understand, and sign a consent...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07575399 · Amgen Phase 3 · 2 countries Recruiting
Recruiting Phase 3 Est. completion 3 January 2028
Puerto Rico🇺🇸 US

Who might be able to join this trial: - People with a Body Mass Index (BMI) of 25 or higher at the time of screening (BMI is a measure of body weight relative to height) - People who have already lost 10% or more of their body weight while taking a weekly GLP-1 RA medication (a type of weight management injection) - Pe...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07589322 · Tri-Service General Hospital (TSGH) Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2028
🇹🇼 TW

**Who might be able to join this trial:** - You are between 20 and 65 years old - Your body weight falls into the overweight or obese range (BMI of 27 or higher) AND you have been told you have metabolic syndrome (a group of conditions including things like high blood pressure, high blood sugar, and abnormal cholestero...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07597018 · Novo Nordisk A/S Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 28 May 2027
🇩🇪 DE

Who might be able to join this trial: - People who are between 18 and 64 years old (inclusive) at the time of signing the consent form - People whose Body Mass Index (BMI) — a measure of body weight relative to height — falls between 27.0 and 34.9, where the extra weight is due to excess body fat as determined by the s...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07599072 · Nazarii Kobyliak Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 May 2027
🇺🇦 UA

Who might be able to join this trial: - Adults aged 18 years or older. - People who have been diagnosed with prediabetes according to American Diabetes Association guidelines. - People who are managing their prediabetes with diet and exercise only, or with a stable dose of metformin taken for at least 3 months before t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07604610 · National Medical Research Center for Therapy and Preventive Medicine Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2027
🇷🇺 RU

Who might be able to join this trial: - People between the ages of 50 and 70 who are having a type of heart ultrasound called a transthoracic echocardiogram, either as a hospital inpatient or at an outpatient clinic - People who are willing and able to agree to take part by signing a consent form Who may not be able t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07607730 · Children's Mercy Hospital Kansas City Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2027
🇺🇸 US

**Who might be able to join this trial:** *For the young person with Prader-Willi Syndrome:* - People aged between 13 and 17.5 years old - People who have a confirmed genetic diagnosis of Prader-Willi Syndrome - People who are fluent in spoken English - People who are able to communicate using flexible phrases or more...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07611240 · Ataturk University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 June 2026
Turkey (Türkiye)

**Who might be able to join this trial:** - Adults between 18 and 65 years of age - People who are scheduled for planned (non-emergency) back surgery involving the placement of hardware or implants in the lower spine - People with a body mass index (BMI) between 30 and 34.9 (a measure of body weight relative to height,...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07614464 · Istituto Auxologico Italiano Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇮🇹 IT

Who might be able to join this trial: This trial has two groups. People may be considered for one of the following groups: **Group 1 – Older adults with obesity:** - People of any sex may be considered - People with a Body Mass Index (a measure of body weight relative to height) above 35 - People aged 65 years or old...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07616232 · Central South University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 8 September 2026
🇵🇰 PK

**Who might be able to join this trial:** - Children between the ages of 6 and 12 who are currently in Grade 3, 4, or 5 at a participating primary school in Lahore, Sahiwal, or Bahawalnagar, Pakistan - Children whose parent or primary caregiver has provided written permission for them to take part - Children who have...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07619989 · The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medic... Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 14 July 2026
🇨🇳 CN

**Who might be able to join this trial:** - People who are living with obesity, or who are overweight and also have at least one weight-related health condition (such as high blood pressure or fatty liver disease), who have been taking a type of weight-loss medication called an incretin receptor agonist for at least 6...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07625969 · Nanjing Medical University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 July 2026
🇨🇳 CN

"Who might be able to join this trial: - People who are currently enrolled as college students - People who are willing to take part in the trial Who may not be able to join: - No exclusion criteria have been listed for this trial Important: Always verify eligibility with the trial site directly before applying."

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07633639 · China-Japan Friendship Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2028
🇨🇳 CN

**Who might be able to join this trial:** - People who are having a laparoscopic sleeve gastrectomy (a type of weight-loss stomach surgery) for the first time. - People with a Body Mass Index (BMI) of 30 or higher, which is a standard measure of body weight relative to height. - People who have been diagnosed with meta...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07639021 · Novo Nordisk A/S Phase 2 · 2 countries Recruiting
Recruiting Phase 2 Est. completion 12 July 2027
Puerto Rico🇺🇸 US

Who might be able to join this trial: - People who were male or female at birth, including all gender identities - People who are 18 years of age or older at the time of signing the consent form - People with a Body Mass Index (BMI) of 30 or higher at the screening appointment (BMI is a number calculated from height an...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07650149 · Jan Kochanowski University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2027
🇵🇱 PL

Who might be able to join this trial: - People aged between 18 and 60 years old - People who are willing to take part and sign a written consent form - People who are overweight or obese, with a BMI (body mass index) above 27 Who may not be able to join: - People for whom the study medication (tirzepatide) would be me...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07653412 · National and Kapodistrian University of Athens Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 January 2027
🇬🇷 GR

Who might be able to join this trial: - People who are 18 years of age or older - People with a BMI of 40 or above, or a BMI of 37 or above along with other related health conditions such as diabetes or high blood pressure (confirm with trial site) - People who are starting treatment with semaglutide or tirzepatide (we...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07654179 · Riphah International University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 11 June 2027
🇵🇰 PK

**Who might be able to join this trial:** - Adults aged 18 or older, of any gender - People who have been diagnosed with recurring (repeat) depression, classified under the international disease code ICD-11 (6A71) - People whose body weight falls into the overweight or obese range using the Asian measurement standard...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07654439 · Selcuk University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2026
Turkey (Türkiye)

Who might be able to join this trial: - People with a Body Mass Index (BMI) of 25 or higher, which is generally considered overweight or obese. - People who are able to walk around on their own without assistance. - People aged between 18 and 65 years old. - People who are willing to take part voluntarily and sign a co...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07656727 · BioAge Labs, Inc. Phase 2 · 2 countries Recruiting
Recruiting Phase 2 Est. completion 30 November 2026
Puerto Rico🇺🇸 US

Who might be able to join this trial: - Adults (both men and women) who are obese with a body mass index (BMI) between 32 and 42 - People who have a blood test result showing raised levels of a marker called hsCRP, which indicates ongoing inflammation in the body - People who have at least one risk factor for heart dis...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07657286 · Badr University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 7 September 2026
🇪🇬 EG

Who might be able to join this trial: - People who have had a sedentary (mostly inactive) lifestyle for at least three months before joining the trial - People with a body mass index (BMI) between 30 and 35, which is a measure of body weight relative to height Who may not be able to join: - People who use tobacco prod...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07662330 · Shanghai 10th People's Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇨🇳 CN

**Who might be able to join this trial:** - People aged 18 to 65 years, of any sex - People with a body mass index (BMI) of 24 or higher, without serious long-term health conditions - People who are not currently taking medications to lower blood sugar or cholesterol - People with abnormal blood fat levels — specifical...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07663942 · Hospital de Sao Sebastiao Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 20 October 2030
🇵🇹 PT

Who might be able to join this trial: - Women aged 18 or older - People with a body mass index (BMI) between 30 and 45 (a measure of body weight relative to height) - People who are already scheduled to have a sleeve gastrectomy or gastric bypass weight loss surgery for the first time - People who are able to understan...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07665879 · Eli Lilly and Company Phase 1 · 2 countries Recruiting
Recruiting Phase 1 Est. completion 1 August 2027
🇩🇪 DE🇸🇪 SE

**Who might be able to join this trial:** - People whose HbA1c blood sugar level (a measure of average blood sugar over time) was below 6.5% at the initial screening appointment. - People with a body mass index (a measure of body weight relative to height) between 25 and 45 kg/m². - People whose body weight has been s...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07665983 · University of Michigan Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2028
🇺🇸 US

**Who might be able to join this trial:** - The baby's biological mother is also the baby's legal guardian and has the baby in her care for at least 5 days per week - The mother is 18 years of age or older - The mother can understand spoken and written English well enough to give consent, complete questionnaires, and f...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07672821 · Medipol University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
Turkey (Türkiye)

Who might be able to join this trial: - Adults between 18 and 65 years old who are living with obesity and have not had weight loss (bariatric) surgery - Adults between 18 and 65 years old who are living with obesity, have had weight loss (bariatric) surgery, and lost less than a certain amount of weight within 18 mont...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07673900 · Terrestrial Bio, Inc. Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 10 February 2027
🇺🇸 US

**Who might be able to join this trial:** - People who are in good general health, with no significant medical history, and whose blood tests, urine tests, and vital signs come back normal at the screening visits - People who are between 18 and 60 years old at the time of screening - People whose body mass index (BMI...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07685483 · Universite du Littoral Cote d'Opale Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2029
🇫🇷 FR

**Who might be able to join this trial:** - People aged 18 years or older. - People with a BMI of 40 or above, or a BMI of 35 or above with health conditions related to obesity, or a BMI of 30 or above with disordered or problematic eating behaviours. - People who are already enrolled in a medical or weight management...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07690176 · Wageningen University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 July 2026
🇳🇱 NL

**Who might be able to join this trial:** - Healthy men and women who are using contraception during the study and for 3 months after it ends - People aged between 18 and 65 years old at the time of signing the consent form - People with a body mass index (BMI) either between 18.5 and 25, or between 30 and 35 (confirm...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07703371 · JSS MEDICAL COLLEGE, JSS ACADEMY OF HIGHER EDUCATION AND RESEARCH Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 16 October 2026
🇮🇳 IN

**Who might be able to join this trial:** - Adults between 20 and 60 years of age - People who are willing to give their formal consent to participate in the study - People who are willing to eat Kodo millet porridge every day for 12 weeks - People who do not plan to change their diet or exercise habits during the stud...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07703683 · Cliniques universitaires Saint-Luc- Université Catholique de Louvain Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2056
🇧🇪 BE

Who might be able to join this trial: - People who have a metabolic or endocrine disease (a condition affecting how the body processes energy or how hormones work) Who may not be able to join: - People who have a known muscle disease (called myopathy) - People who use high-dose steroid medications (more than 1 mg/kg o...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Advocacy and support in Australia

Organisations that can offer information, support, or connection for Obesity. Where more than one is listed, they serve different needs or regions, so choose whichever fits your situation.

Weight Issues Network (WIN) is the national lived-experience patient advocacy organisation for people affected by obesity. Obesity Australia is a related registered charity, the legal entity behind The Obesity Collective.

This is a starting point, not medical advice or an endorsement. Contact details change; search the organisation name to find its current website.